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1. INTRODUCTION 
 
During the last decade, traditional medicinal systems are gaining more importance 
when compared with conventional medicinal systems of the world. One such is the Siddha 
system. The Siddha system of medicine was introduced by the ancient scientists “Siddhars’’ 
who were the spiritual adepts, super human beings with high culture and intellectual abilities. 
The main goal of the siddha medicine is 
 To make one mentally and physically perfect 
 To make body imperishable 
 To promote longevity 
Siddha system is found to be a developed system of medicine yet to be analysed and 
adopted, under which the science can be understood by the chemistry of exhaustive 
complicated preparation of medicines which may not be even imagined in ancient days. 
Heaped up theories with lavish treatment protocols were provided by Siddhars which are yet 
to be validated safe and effective to satisfy the progressing scientific society. 
There are lot of diseases classified under Siddha system in which “puttru” is a life-
threatening malignant condition. Based on the sites of malignancies, they are named as 
puttru/kanna puttru are the malignant conditions of the oral cavity. 
 Symptoms of kanna puttru as explained in Siddha text are as follows; 
 Whitish plaques beneath the tongue 
 Shooting pain in the ear along with head ache 
 Drooling of saliva 
 Nausea  
 Hyperhidrosis  
 Numbness of occipital region [1] 
Literary evidences have a classic collection of herbal, mineral, herbo- mineral 
medicines for Carcinoma, with safety and efficacy yet to be scientifically validated. Several 
anti-cancerous drugs are now in practice in Siddha medicine such as Chithiramoola kuligai, 
Saaranaive kudineer,etc., Apart from the internal medications, Siddhars performed an 
external procedure called  “cauterisation” for treatment of cancerous growth[2]. 
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The above mentioned condition “puttru” may be compared to carcinoma of modern 
age and so kanna puttru can be compared with oral carcinoma. 
Oral Squamous Cell Carcinoma [OSCC] 
 Oral Squamous Cell carcinomas (OSCC) are cancers originating from the squamous 
epithelium in the oral cavity. Locations include the lip, tongue, buccal mucosa, labial mucosa, 
floor of the mouth, gingiva, hard palate and soft palate
[3]
. 
Carcinoma is found to be one of the leading   fatal and   life threatening conditions 
worldwide. According to WHO , there were 14 million new cancer cases , 8.2 million cancer 
deaths and 32.6 million people living with cancer (within 5 years  of diagnosis) in 2012 
worldwide.
[4]
 The overall age standardised cancer incidence rate is almost 25% higher in men 
than in women, with rates of 205 and 165 per 1,00,000   respectively. Expected rise of new 
cases over the next 2 decades will be about 70% (   from 14 million in 2012 to 22 million) 
[5]
. 
Around one third of cancer deaths are due to 5 leading behavioural and dietary risks: 
 High body mass index 
 Lack of physical activity 
 Tobacco use 
 Alcohol use. 
Tobacco use is the single most important   risk factor for cancer causing about 20% of 
global cancer deaths and around 70% of global lung cancer deaths 
[6]
.Another major risk 
category is oral cancer. Oral cancers are a group of cancers commonly referred as head and 
neck cancers. 
 According to American cancer society, men face twice the risk of developing oral 
cancer as women and men who are over age 50 face the greater risk.It is estimated that over 
40,000 people in the U.S received a diagnosis of oral cancer in 2014. 
An epidemiologic and clinical review published in Journal of community health, 
reveal that there is a high prevalence of oral cancer in Indian community. Statistical analysis 
shows the prevalence is about 1.12%
[7]
. 
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Another study was done by the Department of Public health and Primary care, 
University of Cambridge in India about the challenges of oral cancer burden in India. This 
study says Oral cancer ranks in the top three of all cancers in India, which accounts for over 
30% of all cancers reported in the country. In India age-adjusted rates of oral cancer is high 
that is 20 per, 1,00,000   population  & accounts for over 30% of all cancers in the country
[8]
. 
Experts of National Institute of Health & Family welfare (NIHFW) prepared reports 
recently which mainly focus on the harmful effects of gutka, which clearly specifies that 
India alone accounted for 86% of total oral cancer across the world. Chewing tobacco and 
gutka contribute to 90% of oral cancer cases in the country 
[9]
. 
The most common risk factors for oropharyngeal cancer include the following: 
 Being infected with human papillomavirus (HPV). The number of oropharyngeal 
cancers linked to HPV infection is increasing. 
 A history of smoking for more than 10 pack years. 
 Heavy alcohol use 
[10]
. 
Treatment for Oral carcinomas majorly includes chemotherapy and radiation therapy.  
Chemotherapy is the use of anti-cancer (cytotoxic) drugs to destroy cancer cells. 
Chemotherapy drugs work by disrupting the growth of cancer cells. The most commonly 
used Chemotherapy drugs for head and neck cancer is Cisplatin.  
Other chemotherapy drugs that  may be used 
include Carboplatin, Docetaxel (Taxotere),Gemcitabine and Fluorouracil (5FU)
[11]
. 
Adverse effects of chemotherapy 
Myelosuppression, nausea, vomiting, hyperuricaemia, alopecia etc 
Present studies stress on the fact of increasing toxicity due to Chemotherapy, 
specifically in head and neck cancer such as Mucositis (painful inflammation and 
ulcerations of the mucous membranes) and Xerostomia (dryness of mouth) as a major 
manifestation of chemotherapy and radiation therapy respectively.There are additional 
studies under way to address the long-term side effects as well as the acute toxic effects of 
combination therapy to the head and neck region
[12]
. 
  The adverse side effects  of chemotherapy is a rising burden for the Cancer affected 
community which affects their routine day to day activities to a great extent both mentally 
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and physically, which naturally leads to a urge of searching safe treatments with less side 
effects.
[13] 
And thus, there is a need of searching traditional healing in a smoother way. In 
addition to herbal treatments, a huge number of Herbo-mineral and metallic preparations are 
found in Siddha literatures, one among those is “ASHTA BAIRAVA CHENDURAM” ,which is 
a red oxide product with the ingredients  Red Orpiment, Yellow Arsenic Trisulphide, 
Magnetic Oxide of Iron, Hydragyrum Subchloride, Red Sulphide of Mercury, Hydragyrum, 
Sulphur, White Arsenic and fresh juices ofAcalypha indica, Piper betle, Gossypium 
herbaceum, Enicostema axillare, Ocimum sanctum.  
Researches bring into limelight that the  above compounds of Arsenic and Sulphur are 
found to have Anti-oxidant activity and Anti-tumour activity to an extent that they could be 
used in conditions where the affected are intolerable to chemotherapy
[14]
. 
 Anti-tumour activity of Arsenic compounds 
 Anti-oxidant activity of Arsenic trioxide 
 Synthesis and Anti-tumour Activity of sulphur-containing 9-Anilinocridines[15] 
Piper betle has cytotoxic activity as well as microbial activity,  Acalypha indica possess 
Anti- oxidant and Anti- cancer activities, Acalypha indica possess potent Anti-cancerous 
property,  Ocimum sanctum possess antioxidant, anticancer, chemopreventive, radio 
protective, immunomodulatory activities, Enicostemma axillare shows greater activity on 
HeLa cell line and that mean Enicostemma axillare can be used in anticancer activity 
[15]
. 
Another study reveals that Enicostemma axillare is also having anti-oxidant 
activity
[16].
Gossypium herbaceumis found to have Anti-viral activity and Anti –Bacterial 
Activity which is highly essential in treating HPV induced Oral 
Carcinoma
[16][17][18][19][20][21][22]
. 
Thus, the drug Ashta Bairava chenduram is taken for analysis of Anti-cancer, Anti-
tumour, Anti-oxidant activities that it can be evolved into a better treatment for Cancer 
compared to chemotherapy. 
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2. AIM AND OBJECTIVE 
 
AIM: 
To justify the ancient Siddha drug for management of oral cancer with its ultimate 
formulation and give good progress to the people affected by oral cancer. The purpose of the 
present study was aimed to evaluate the activity of Ashta Bairava Chenduram for its efficacy 
in managing Oral Cancer through pre-clinical aspects. In the present medical world, there is a 
need for proper treatment for Oral Cancer. The aim of this study is evaluation of a new drug 
for the management of oral cancer. 
 
OBJECTIVES: 
     The key objectives of the study are: 
 Having a collective review of the literature. 
 Preparing the drug according to Siddha classical text. 
 Subjecting the drug to physico-chemical standardization. 
 Analyzing the drug chemically for detection of acid and basic radicals. 
 Focusing the drug for analytical assessment. 
 Studying the toxicity profile of Ashta Bairava Chenduram according to OECD 
guidelines. 
 Determining the pharmacological activity (In Vitro Anti-cancer activity) of Ashta 
Bairava Chenduram . 
 Analyzing all the above study results to evaluate the benefits of Ashta Bairava 
Chenduram . 
 
REVIEW OF LITERATURE 
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3. REVIEW OF LITERATURE  
3.1 SIDDHA REVIEW 
SIDDHA ASPECT OF MANOSILAI (REALGAR):  
Synonyms:  
 Realgar 
Chemical names: 
 Arsenic Disulphidum, Bisulphuret of Arsenic  
Types: 
Manosilai (Bisulphuret of Arsenic) is of two types 
   1. Piravi sarakku    – It is naturally available. 
 2. Vaippu sarakku – It is obtained by adding 5 parts of Arsenic trioxide and 3 parts of 
Sulphur. 
General properties: 
             “.…………………………………….. க ொடி஦ குஷ்டம் 
 ொய்ச்சல்஢டுக் னஜ  ல்னி஦ிர஧ப் புச்சினந்஡ிப் 
 பதசறு஥ பணொசிரனக்குப் பதசு”.  
 -த஡ொர்த்஡ கு஠ சிந்஡ொ஥஠ி.           
 It has got body strengthening and rejuvenating properties. Its potency is good. This is 
effective in the treatment of leprosy, fever with chills, asthma, eye diseases, urinary tract 
infections, kapha diseases and cervical adenitis. 
Method of purification: 
 Manosilai is triturated with any one of the following for 3 hours, Ginger juice, lemon 
juice or butter milk, it is then dried to get purified form. 
Medicinal uses: 
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 It is mostly not used alone but in combination with other drugs, pills and oil. The oil 
is effective in the treatment of fistula. The pill is effective in the treatment of fever with 
chills. 
Other medicines: 
 Kasthuri karuppu, Vishnu Sakkara maththirai, Gandhaga urundai, Paashana 
maththiarai, Bramananda bairavam, Sivanar amirtham, Santhirothaya maththirai
[23A]
. 
3.2  MODERN ASPECT OFREALGAR: 
Realger, α-As4S4 is an Arsenic Sulphide mineral, also known as ―Ruby Sulphur‖. It is orange-
red in colour, melt at 320
0
C,and burns with the bluish flame releasing fumes of Arsenic and 
Sulphur. It is a photosensitive mineral and will alter to Para Realger upon prolonged exposure 
to light. It has an Arabic name Rahj al ghar which means "powder of the mine." 
Other names:   Ruby Sulphur, Ruby of Arsenic. 
Physical Properties: 
Formula                   -    As4S4 or AsS 
Colour                     -    Red to yellow-orange  
Density                    -              3.56 
Diaphaneity             -   Transparent 
Specific gravity       -              3.56  
Melting point           -   320 °C 
Molecular Weight    -   106.99 gm 
Refractive index       -    2.538 
Luminescence           -    Non-fluorescent 
Lustre                        -  Sub Metallic 
Streak                        -   Orange 
Electrical Properties: 
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Electron Density        -   3.30 gm / cc 
Fermion Index           -    0.0022478773 
Boson Index              -    0.9977521227 
Radioactivity             -  0 GRapi (Gamma Ray American Petroleum Institute Units) 
[24]
 
Uses:  
The Chinese name for Realgar is Xionghuang, literally 'masculine yellow'. It was used to 
repel snakes, rats, weeds and insects, as well as being used in Chinese medication. The 
ancient Greeks called it as ―Sandaracha‖. It is used in combination with Potassium Chlorate 
to make a contact explosive known as "red explosive" for some types of torpedoes
[25]
. 
SIDDHA ASPECTOF THAALAGAM (ORPIMENT):  
Synonyms:  
 Orpiment 
Chemical names: 
             Yellow Arsenic Trisulphide, Trisulphuret of Arsenic 
Other names: 
              Peethagi, Aalmbi, Paluppu, Kothantham, Maalam, Arithaaram, Kaalpuththi, 
Ponvarni, Manjal varni, Maaldevi and Arithalam 
Types: 
 Depending upon the colour, appearance and properties, Thaalagam has beenclassified into 
four types. 
1. Sivappu Aridharam (Red Orpiment) 
2. Madal Aridharam  
3. Pon Aridharam (Gold Orpiment) 
4. Karattu Thalagam 
General properties: 
“஡ொப த்஡ின் பதபேர஧க் ஡த் ஡ொலு வுள் ப஢ொய்குஷ்டம்  
REVIEW OF LITERATURE 
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஢ீபக் குபிர் ொய்ச்சல் ஢ீடு தம் – ஢ொபொ ங்க ொள் 
துஷ்டப் தநங் ிப்புண் சூ஫ழு ண் ஥ண்ரடப஢ொய் 
 ிட்டப் தடுத஥ொ  ிபத்து” 
-த஡ொர்த்஡ கு஠ சிந்஡ொ஥஠ி . 
             It is effective in the treatment of skin diseases, diseases of head and tongue, fever 
with chills, kapha diseases, urinary tract diseases, and venereal focus ulcer in the urethra. 
Actions:  
              Expectorant, antipyretic, convalescent, tonic, emetic 
Other medicines: 
Thalaga ennai (Virana sanjeevi thailam) - Heals chronic ulcers 
Signs and symptoms of yellow Arsenic poisoning: 
           Yellow Arsenic if not prepared properly, the preparation will be toxic. The following 
symptoms are seen, burning pain of the stomach, gastritis, hoarseness of voice, nasal 
bleeding, bleeding from the nail buds, itching over the head and redness in the tip of the hairs, 
mental disorders, lower abdominal swelling and throbbing pain in the lumbar region, 
bronchitis and sciatica. 
Antidote:  
             Root Bark of Ceylon lead wort (Plumbago zeylanica)   _   8.75gm 
             Pepper (Piper nigrum)                                                    –  8.75gm 
             These are added together and made decoction. Culinary salt (4.37gm) is then added 
and the mixture is taken twice daily for 21 to 42 days
[23B]
. 
 
MODERN ASPECT OF ORPIMENT: 
Orpiment is a deep orange-yellow colored Arsenic Sulfide mineral. Its formula is As2S3. It is 
formed by sublimation of Arsenic (60.90%) and Sulphur (39.10%). It takes its name from the 
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Latin Auripigmentum (Aurum − Gold + pigmentum − pigment) because of its deep-yellow 
color. 
Synonyms:  
Arrhenicum Operment, Oropiment, Yellow Arsenic, Yellow Ratsbane, Auripigment, 
Arsenicum flavum 
Physical Properties: 
Colour                     -               Lemon yellow, Orange yellow 
Density            -               3.49 - 3.56, Average = 3.52 
Molecular Weight   -    246.04 gm 
 Melting point         -    300 °C to 325 °C 
Diaphaneity             -   Transparent to translucent 
Fracture            -   Sectile  
Crystal Habit            -   Foliated  
Hardness             -    1.5-2 - Talc-Gypsum 
Luminescence          -   Non-fluorescent 
Luster            -    Pearly 
Streak            -    Pale yellow 
 Electron Density     -   3.23 gm / cc 
Specific Gravity       -   3.49 gm / cc 
Fermion Index          -    0.0029323747 
Boson Index             -   0.9970676253 
Photoelectric             -   44.66 barns / electron 
Radioactivity             -    0 GRapi (Gamma Ray American Petroleum Institute Units) 
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Chemical Properties: 
Formula             -   As2S3 
Elements              -   As, S 
Common Impurities   -   Hg, Ge, Sb 
[26]
 
Uses: 
Orpiment was traded in the Roman Empire and was used as a medicine in China. It has been 
used as a fly poison and to tip arrows with poison. Because of its Golden color, it was used 
by alchemists, both in China and the West, searching for a way to make Gold
[27]
. 
SIDDHA ASPECT OF KAANTHAM (MAGNETIC OXIDE OF IRON): 
Chemical name – Magnetic oxide of Iron 
Other names: 
Sivaloga Sevagan, Tharanikku Naatham, Sootha Angusam, Navaloga Thurati, 
Kaayachithikku Paathiravan, Murugan Puranam. 
Types: 
             There are five varieties of Kaantham 
1. Kal kaantham (Piramugam) 
2. Oosi kaantham (Kambagam) 
3. Pachai kaantham (Karshagam) 
4. Arakku kaantham (Dhiravagam) 
5. Mayir kaantham (Romagam) 
General properties: 
                 “ ொந்஡த்஡ொற் பசொரதகுன்஥ங்  ொ஥ினப஥  ம்தொண்டு 
பசர்ந்஡஡ிரி ப஡ொடக஬ட்ரட சீ஡ங் ொல் – ஓய்ந்஡தசி 
 பதபே஡஧ங்  ண்ப஠ொய் தி஧஥ி஦஢ீ ஧ொர஥ப௅ம்பதொம் 
ஓரிணிரந ஦ொபெல௃றும் உன்”.  
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-த஡ொர்த்஡ கு஠ சிந்஡ொ஥஠ி.   
          In general, the Kaantham has got the similar properties as Iron. However, it is 
considered that Kaantham issuperior to Iron in many aspects. This is very effective in the 
treatment of swelling, ulcer, jaundice, venereal diseases, kapha vatha diseases, leucorrhoea, 
dyspepsia, gonorrhea, anasarca, eye diseases and splenomegaly. It also increases one‘s life 
span. 
Method of purification: 
           Magnetic oxide if Iron                                              - 35 gm 
           Root bark juice of Ponnavarai (Cassia auriculata) - 210 gm 
           Magnetic oxide of Iron is soaked in root bark juice of Ponnavarai and isolated from 
morning to evening for ten days. Then it is dried for two days without adding the juice. This 
process is repeated twice and washed to obtain purified Magnetic oxide of Iron 
[23C]
. 
MODERN ASPECT OF MAGNETIC OXIDE OF IRON: 
Other names: 
            Iron (II, III) oxide, Iron (II) Iron (III) oxide 
Magnetite is an important ore of Iron. It is a natural Iron oxide Magnet, hence the name, 
giving it a very nice distinguishing characteristic. It is the most magnetic of all the minerals 
on Earth. In Magnetite, Fe3O4, the A metal is Fe +2 and the B metal is Fe +3; two different 
metal ions in two specific sites. This arrangement causes a transfer of electrons between the 
different ions in a structured path or vector. 
Distribution: 
Magnetite is sometimes found in large quantities in beach sand. Such mineral sands / black 
sands are found in various places such as California and coastal area of New Zealand.  
Properties: 
Colour     - Black to grayish 
Molecular formula       -   Fe3O4, FeO.Fe2O3 
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Molar mass    -  231.533 g/mol 
Appearance    -   solid black powder 
Density     -   5 g/cm3 
Melting point    -    1538 °C 
Refractive index (nD) -     2.42 [1] 
 Luster    -   Metallic 
 Tenacity     -   Brittle 
 ID Mark    -   Ferromagnetic 
 Solid Density      -    5.1(gm/cm3)    
pH    -    7 
 Transparency    -   Opaque 
  Hardness      -    5.5 to 6.5 
 Fracture    -   Conchoidal   
 Specific Gravity    -    5.17 to 5.18 
Crystal System   -   Isometric 
Medicinal Uses: 
Nanoparticles of Fe3O4 are used as contrast agents in MRI scanning. Ferumoxytol is 
an intravenous Fe3O4 injection for treatment of anemia resulting from chronic kidney failure.  
Other Uses: 
 Magnetite is used as a black pigment and is known as C.I pigment black 11. It is used 
as a catalyst in the Haber process and in the water gas shift reaction. It is used as a pigment 
for Magnetic applications, polishing compounds and cosmetics. 
[28]
 
SIDDHA ASPECT OF POORAM (CALOMEL): 
Synonyms:  
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                  Calomel 
Chemical names: 
             Hydragyrum Subchloride 
  All though the calomel does not find a place in the list of 64 Paadanaas, it is 
considered as one among them by the medical practitioners. It is a combination of Rasam 
(Mercury) and salt. 
Method of Preparation of Pooram: 
 Sulphur 67.2 gm is melted in a mud pot and Mercury 33.6 gm is added to it and 
kindled well to get a black coloured powder. Brick powder is placed up to the half of the 
level of a pot. Culinary salt (Nacl) – 650 gm is placed over it. Mercury and Sulphur mixture 
is placed over the salt and sealed with mud pasted cloth. It is burnt for 12 hours with 
Kaadakkini. After it is cooled the Mercurous Chloride is found deposited on the upper pot 
and the same are collected.                 
General properties: 
     “இரட஬ொ஡ சூரன எரிசூரன குன்஥ந் 
க஡ொரட஬ொர஫ ஬ொ஡஥ொஞ் பசொ஠ி – ஦ிரட஦ொப஡ொ 
க஬ொக்கு஧ச  ற்பூ஧ க஥ொன்பந ஦ொபக஬ொடு஢ல் 
இக்கு க஬ல்னத்ப஡ழு ஢ொப”ீ. 
 -த஡ொர்த்஡ கு஠ சிந்஡ொ஥஠ி . 
                It cures throbbing pain, pain in the lumbar region, burning sensation, ulcer due to 
disorder of vatha humour, hepatomegaly, pyrexia, jaundice, bacillary dysentery, dropsy, 
chronic ulcers, venereal diseases, vomiting, diarrhea, worm infestation, rheumatism, itching, 
constipation, scabies and headache. 
                Taste   –   salty 
                Potency   –  hot 
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                Action   –  Laxative, tonic, antiseptic and diuretic 
Purification method of Calomel: 
                  The poultice made of Betel leaf (Piper betle) and Peper (Piper nigrum) each 8.75 
gm are taken and dissolved in 1.3litre of water. Calomel (50 gm) is tied with the cloth and 
immersed in the liquid form the cross bar and heated. After the water is reduced to ¾ of its 
volume. The Calomel is taken out, washed with water and dried to get purified Calomel.      
Toxic symptoms of Calomel: 
                  Multiple red boils appear on the face, acne formation, ulcers in the chest, mouth 
and tongue, diarrhea, dysentery, scrotal swelling, and ulcer in the uvula. 
Antidote: 
                  Black musali tubers (Curculigo orchiodes)  -  8.75 gm 
 Indian penny wort root (Centella asiatica)      -  8.75 gm 
Root of sessile plant (Alternanthera sessilis) -   8.75 gm 
Beetle killer (Cleodendrum serratum) -   8.75 gm 
                  All these ingredients are mixed together and boiled to make a decoction. It is used 
twice a day for two or three weeks with suitable diet restrictions. 
Other preparations: 
  Rasa Karpoora Kuligai   -   Vulval Cancer, penile Cancer, chronic ulcer, deep            
ulcers and syphilis 
  Poora Kalimbu                -  Syphilitic ulcer 
  Poora Ennai                    -    Venereal diseases, ulcers 
  Poora Podi                      -   Venereal ulcer occurring on penis 
[23D]
 
MODERN ASPECT OF CALOMEL: 
Mercury (I) chloride is odourless solid and dense white or yellowish-white in colour. 
It is the principal example of a Mercury (I) compound. It is composed of Mercury and 
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chlorine (Mercury   84.98 % Chlorine 15.02 %). It is also referred to as the mineral horn 
quickSilver or horn Mercury. 
Properties: 
Molecular formula    -     Hg2Cl2 
Molar mass     -    472.09 g/mol 
Molecular Weight    -    472.09 gm 
Appearance     -   White solid 
Specific      -   7.27 gm / cc 
Density   -   7.150 g/cm3 
Melting point    -   525 °C (triple point) 
Boiling point     -   383 °C (sublimes) 
Solubility in water  -          0.2 mg/100 ml 
Hardness     -   1.5-2 - Talc-Gypsum 
Refractive index   -    1.973 
Fermion Index     -           0.25 
Boson Index      -    0.75 
Radioactivity    -   0 GRapi i.e not radioactive (Gamma Ray American Petroleum 
Institute Units) 
Other anions     -   Mercury (I) fluoride, Mercury (I) bromide, Mercury (I) iodide 
Other cat ions               -     Mercury (II) Chloride 
[29]
 
Medicinal properties: 
Calomel was used internally to treat yellow fever during its outbreak in Philadelphia 
in 1793 and also used in the treatment of syphilis, until early 20th century.  It used as a 
laxative and disinfectant. During 18
th
 century American Doctors used Calomel to make 
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patients regurgitate and release their body from "impurities". It was a common ingredient in 
teething powders, soaps and skin lightening creams in Britain up until 1954
[30]
. 
SIDDHA ASPECT OF LINGAM (CINNABAR): 
Synonyms:  Natural Cinnabar, Vermilion. 
Chemical name:  Red Sulphide of Mercury. 
Other names:  
Inkuligam, Raasam, Kadai vanni, Karpam, Kalikkam, Kaanjanam, Kaaranam, Sandagam, 
Samarasam, Saaniyam, Chendooram, Maniragam, Milechem, Vani andVanni. 
Nowadays, The Lingam used by us is called as Jaathi linga paadanam, grouped under 
Vaippu paadanam. 
Preparation of Vaippu paadanam: 
                       Rasam (Mercury)                     –   280 gm 
                      Gandhagam (Sulphur)              –   70 gm 
                      Vediuppu (Pottassium nitrate)   – 70 gm 
Procedure: 
Mercury is thoroughly mixed and triturated with Sulphur. Potassium nitrate is then 
added, placed in a conical flask and burnt for 18 hours, after cooling the red Sulphide of 
Mercury is collected out. 
Gunam (Properties): 
 It is hard, when it is put into fire it developes smoke; not soluble in water, has no 
smell and taste and has hot potency. 
General properties: 
“பத஡ிசு஧ஞ்சந்஢ி கதபே஬ி஧஠ ஢ீப஧ொடு஡ 
 ொ஡ டி  ொசங்  ஧ப்தொன்புண் – ப஠ொ஡ 
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       வுபே஬ினிங்  சங் ஡஥ொ பெறு ட்டி ப௅ம்பதொங் 
       குபே஬ினிங்  சங் ஥த்ர஡க் க ொள்.” 
 -த஡ொர்த்஡ கு஠ சிந்஡ொ஥஠ி.   
  It is effective in the treatment of diarrhea, pyrexia, delirium, urticaria, diuresis, 
tuberculosis, scabies, unknown insect bites, syphilis, leprosy, eczema, skin diseases, 
throbbing pain and vatha diseases. 
Method of purification: 
 Lime juice, cow‘s milk and the Indian Acalypha juice are mixed together in equal 
proportion and allowed to fuse Cinnabar so as to get it in a purified potent form. 
Other preparation: 
Sanda Rasa Parpam           - syphilis, arthritis, tremor, delirium and venereal diseases 
Padigalinga Chendooram   - dysentery, diarrhea, menorrhagia and fever 
Saathi Sambera Kuzhambu - diarrhea, nausea, vomiting, syncope, fever and thirst 
Sign and symptoms of Cinnabar toxicity: 
 Dyspepsia, loss of taste, ulcers in the buccal floor, uvula, inner portion of the tongue, 
larynx and large intestine, foul odour from mouth, discharge of viscous, whitish saliva 
burning sensation are the toxic symptoms of red Cinnabar. 
Antidote: 
          Nutmeg (Myristica fragrans)                                      -   4.2 gm 
          Cubeb pepper (Piper cubeba)                                      -   4.2 gm 
          Root bark of red cotton tree (Gossypium arboretum) -   4.2 gm 
          Sugar candy                                                                 -   4.2 gm, 
 These are mixed together and made into decoction and administered twice daily for 
48 days. 
[23E]
 
REVIEW OF LITERATURE 
 
ANTI-CANCER ACTIVITY OF ASHTA BAIRAVA CHENDURAM |  19 
 
MODERN ASPECT OF CINNABAR: 
Cinnabar   (red Mercury (II) Sulfide (HgS), vermilion) is the ordinary ore of Hg.  It is 
normally found in a substantial, granular form and is bright scarlet to brick-red in color.   It is 
a chemical compound composed of the chemical elements Mercury and sulphur (Mercury 
86.22 % Sulphur   13.78 %).  
Formula              -  Mercury (II) sulfide 
Symbol              -  HgS 
Properties: 
Molecular formula    -     HgS 
Number                     -    32 
Colour                       -  brownish red and lead-gray 
Specific gravity         -            8.176  
Solubility                   -    Soluble in water,  
Molecular Weight      -    232.66 gm  
Melting point             -    580 °C decomp.  
Other anions              -   Mercuryoxide, Mercury selenide, Mercury telluride 
Other cations             -  Zinc sulphide, Cadmium sulphide 
Fermion Index           -    0.26 
 Boson Index              -  0.74 
Radioactivity              -    0GRapi i.e not radioactive (Gamma Ray American Petroleum 
Institute Units) 
[31]
 
Toxicity: 
  It caused shaking, loss of sense, and death. Over exposure to Mercury is called 
―Mercurialism‖. This was seen as an occupational disease to the ancient Romans [32]. 
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SIDDHA ASPECT OF RASAM:  
Synonyms: Mercury orQuickSilver 
Chemical name: Hydragyrum  
 Mercury is comes under the classification of ‗Pancha soothaam’. It has many 
connotations such has Sootham, Punniyam, Bharatham, Inimai, Sivasathi, Kesari etc, 
according to Dasangu nigandu. 
  Mercury is obtained from its ores in countries like Spain, California, Russia, China 
and Japan. It is separated from its ore Cinnabar. 
Types of Mercury: 
 Mercury was classified into five types. 
1. Rasam 
2. Rasendhiran 
3. Sootham 
4. Misaragam 
5. Baaratham 
Properties: 
1. Vitalizer 
2. Tonic 
3. Laxative 
4. Diuretic 
5. Neutralising pitham 
6. Silagogue 
7. Anti-inflammatory 
8. Medicine for venereal disease (mega nasini) 
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Taste:   Six tastes dominated by sweet 
Potency: Hot and cool (both -speciality) 
Special properties of Mercury: 
 Unlike other drugs Mercury is useful in the treatment of diseases caused by both heat 
and cold. 
Dhosam (Impurities) of Mercury: 
 It is considered that there are two types of Dhosam of Mercury. They are  
 1. Dhosam 
            2. Sattai (Kavasam) 
In Dhosam there are 8 types of impurities in Mercury producing various diseases as shown 
below 
 Impurities                  Disease caused by them 
1. Undheenam              Soolai (Throbbing pain) 
2. Kowdilayam              Kapala noi (Diseases of the head) 
3. AnavarthamBiramai (Manic illness) 
4. SangaramThathu nattum (Spermatorrhoea) 
5. Sandathvam Sattium (distress) 
6.  Panguthvam Kuttam (Leprosy) 
7. SamalathvamMoorchai (Syncope) 
8. SavisthavamSareeraElaippu (Loss of weight) 
Sattai is an another type of classification, there are 7 types of impurities in Mercury which 
produces various diseases as shown below 
Impurities              Diseases caused by them 
1. NaagamMoolam (Haemorrhoids) 
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2. VangamTholnoikal (Skin disease) 
3. MalamArivinmai (Idiocy) 
4. VidamMaranam (Death) 
5. AkkiniThaha moham (Polydypsia) 
6. GiriSattium (Distress) 
7. SabalamThathunattam (Spermatorrhoea) 
General properties of Mercury: 
஬ி஫ிப஢ொய் ி஧ந்஡ிகுன்஥ம்க஥ய்சூரனபுண்குட் 
ட஫ி ொனில்஬ிந்து஬ிணொல்அத்ர஡- ஬஫ி஦ொய் 
புரிப௅஬ி஡ி஦ொதுபுரி஦ிபணொக஦ல்னொம் 
இரிப௅஬ி஡ி஦ொது஥ில்ரன. 
Proper use of Mercury as a medicine can able to cures the following diseases they are disease 
in eyes, syphilis, eight types of ulcers (gunmam), throbbing pain (soolai), chronic ulcers 
(perumpun), leprosy and Hansen‘s disease. 
Purification and detoxification of Mercury: 
 Mercury -35gram 
 Brick powder-required quantity 
 Turmeric powder- required quantity 
 Acalyphaindica juice-1.3 lit 
             Mercury was triturated with finely powdered brick and then turmeric powder for one 
hour respectively and washed with water. Then Mercury is boiled with the juice of Acalypha 
indica till the juice completely evaporates. We get purified Mercury. 
Preparations of Mercury: 
 Sootha karuppu 
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 Rasa mezhugu 
 Rasa thailam 
 Megavirana kalimbu 
 Rasa kuligai[23F] 
 MODERN ASPECT OF MERCURY: 
Mercury: 
Mercury should not have less than 99.5 percent of Hg. It occurs naturally as a sulphide ore 
called Cinnabar HgS. It also occurs in small globules disseminated through rocks and as 
amalgam of Silver and Gold. 
Preparation: 
It‘s obtained by roasting Cinnabar in a current of air  HgS+O2→Hg+SO2 
 The free Mercury gets liberated it may be either purified by volatilization or 
chemically by dropping Mercury into a column of dilute Nitric acid for removing basic 
impurities. 
Properties:  
It has shinning silvery white in nature. Heavy liquid easily divisible into globules and 
extremely mobile it easy volatilizes on heating. It boils at 359.58°C. 
Almost insoluble in water, alcohol and HCl. it dissolves in cold and dilute Nitric acid, giving 
mercurial nitrate and Nitric oxide. 
                     6Hg+8HNO3→ 3Hg2 (NO3)2+2NO+4H2O 
Density:  
13.581ml at 25°C 
Mercurial preparations: 
 Mercury with Chalk (Gray powder) 
 Yellow Mercuric Oxide (HgO) 
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 Mercuric Oxide 
 Oleated Mercury 
 Mercurous Chloride (HgCl-Calomel) 
Tests for Purity: 
 It has been tested for weight per ml (at 25°C is about 13.5g).Non-volatile matter 
residue at 300°C (not more than 0.02℅w/w). 
Assay:  
An accurately weighed quantity (0.49g) is dissolved in equal parts (20ml) of water and Nitric 
acid. It is heated gently until the solution become colourless. The solution is then diluted with 
water (150ml) and sufficiency quantity of Potassium permanganate is added till a permanent 
pink colour is produced. A trace of Ferrous sulphate to discharge pink colour is added. Then 
the solution is titrated with standard 0.1N Ammonium thiocyanate (1ml of 0.1N Ammonium 
thiocyanate =0.01003g), using Ferric Ammonium sulphate as indicator. The temperature 
during the titration should not exceed above 20°C. 
3Hg+8HNO3→3Hg (NO8)2+4H20+2NO↑ 
Hg (NO3)2+2NH4SCN→2NH4NO3+Hg (SCN)2 
Uses: 
It is a pharmaceutical aid and for preparing Mercury with chalk .Formerly metallic Mercury 
found use as such therapeutically as a cathartic and parasticide. But it is more used as such, as 
it has been extremely poisonous and prolonged inhalation of even very minimal amounts of 
Mercury prove fatal. Almost all the salts of Mercury with the exception of the Sulphide, has 
been poisonous. 
1. Mercury with chalk (Grew powder) 
 It is having 31 -35℅ w/w of Mercury and 62-70℅ w/w of CaCO3 
 It is used as a purgative (Dose 60-300mg) 
2. Yellow mercuric Oxide (HgO) 
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 It is having not less than 99.5℅ HgO. It is used as a mild anti-septic, as anti-
infective and anti- bacterial agents. 
3.  Mercuric Oxide: 
 It contains not less than 95℅ but not more than105℅ w/w of the stated amount 
of yellow Mercuric oxide 
 It is used in ophthalmology, 1℅ ointment to treat mild inflammatory 
conditions for the treatment of blepharitis and conjunctivitis. 
4. Oleated Mercury: 
 It has the equivalent of 20℅ of yellow Mercuric oxide 
 It is used as an anti-infective. 
5. Mercuric chloride (HgCl) (Calomel): 
 It is being not less than 99.6℅ of HgCl 
 It has been used for centuries as a cathartic but recently it is replaced by other 
drugs. 
[33]
 
                   Calomel has been insoluble in gastric juice and has been not absorbed from the 
stomach. It gets absorbed in the intestine by the alkaline pancreatic juice where it slowly gets 
dissociated into Mercury and irritant Mercuric compounds which have been exerting a 
cathartic action 
[34]
. 
SIDDHA ASPECT OF GANDHAGAM (SULPHUR)   
Chemical name – Sulphur  
Other names: 
                        Kaarizhain naatham, Parai veeriam, Atheetha prakaasam, Peejam, Sakthi, 
Sakthi peesam, Selvi vindhu, Naatham, Naatram, Deviuram 
General properties:  
Gandhagam is bitter and astringent in taste. Its actions are laxative, tonic and antiseptic. It 
increases the various secretions of the body including skin. When used in high doses, it 
causes diarrhea. 
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Types: 
Gandhagam is divided into four types depends upon their colour, appearance and properties. 
           1. White colored Sulphur 
           2. Red colored Sulphur 
           3. Golden yellow colored Sulphur  
           4. Black colored Sulphur. 
          In addition, gooseberry Sulphur and stick Sulphur (Vaana gandhagam) have been 
mentioned in most of the text books of ancient Siddha medicines. Gooseberry Sulphur is one 
which is often used in medicinal preparations. 
Gooseberry Sulphur (Nellikai gandhagam): 
“க஢ல்னிக் ொய்க்  ந்஡ிக்கு ஢ீள்த஡ிகணண் குட்ட஥ந்஡ம்  
     ஬ல்ரன  ஬ிரசகுன்஥ ஬ொப௅ ண்ப஠ொய் – கதொல்னொ 
஬ிடக் டி஬ன் ப஥ ப஢ொய் ஬றீுசு஧ம் பத஡ி 
஡ிடக் ி஧  ஠ ீதம்பதொந் ப஡ர்”.   
 -த஡ொர்த்஡ கு஠ சிந்஡ொ஥஠ி . 
It is used in the treatment of 18 types of skin diseases, liver enlargement, abdominal 
distension, eye diseases, chronic venereal diseases, chronic diarrhea, gastric ulcer, poisonous 
bites, fever, and chronic dysentery. 
Method of purification: 
           Sulphur is placed in an Iron spoon. A small quantity of cow‘s butter is added and the 
spoon is heated till the butter melts, this mixture is immersed in inclined position in cow‘s 
milk. This procedure is repeated for 30 times to get purified Sulphur. Each time fresh milk is 
to be used. 
[23G]
 
MODERN ASPECT OF SULPHUR: 
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Sulphur or Sulphur is a Greek word which means ―to burn‖. Sulphur is a chemical element 
with the symbol S. It is a plentiful, multivalent non-metal. It occurs in nature as the pure 
element and as Sulfide and Sulfate minerals. Sulphur is referred to in the Bible as brimstone 
(burn stone) in English. 
History: 
It is discovered by Chinese Before 2000BC and is recognized as an element by Antoine 
Lavoisier in 1777. 
General properties: 
Symbol               -   S 
Number                -    16 
Element category        -    polyatomic nonmetal 
Physical properties:  
Phase      -   solid 
Density     -    1.96 g·cm−3 
Liquid density at M.P -   1.819 g·cm−3 
Heat of fusion     -     1.727 kJ·mol−1 
Heat of vaporization   -   45 kJ·mol−1 
Molar heat capacity   -    22.75 J·mol−1·K−1 
Electronegativity  -  2.58 (Pauling scale) 
Chemical properties: 
Solubility     -    insoluble in water 
Vanderwaals radius      -   0.127 nm 
Ionic radius      -   0.184 (-2) nm; 0.029 (+6) 
Isotopes     -   5 
REVIEW OF LITERATURE 
 
ANTI-CANCER ACTIVITY OF ASHTA BAIRAVA CHENDURAM |  28 
 
Electronic shell    -   [Ne] 3s23p4 
Standard potential    -   0.51 V 
Biological role: 
Sulphur is a vital component of all alive cells, it is the seventh most plentiful element in the 
human body by weight, and is used in biochemical processes. The average person takes in 
around 900 mg of Sulphur per day, mainly in the form of protein. In metabolic reactions, 
Sulphur compounds serve as both fuels and respiratory materials. Its organic form is present 
in the vitamins biotin and thiamine. It is an essential part of many enzymes and in antioxidant 
molecules. 
[35]
 
Toxic effects of Sulphur: 
            Elemental Sulphur is nontoxic, but many simple Sulphur derivatives are, such as 
Sulphur dioxide (SO2) and Hydrogen Sulfide are toxic which include neurological effects, 
disturbance of blood circulation, heart damage, reproductive failure, stomach and 
gastrointestinal disorder, dermatological effects. 
[36]
 
SIDDHA ASPECT OF VELLAI PAASHAANAM (WHITE ARSENIC):  
Synonyms: 
White Arsenic 
Chemical names:                          
   Arsenious acid 
Vellai Paashaanam is obtained from nature in the land. It is mostly available in combination 
with other metals such as Sulphur, Iron, and Copper etc. 
General properties: 
               When used in small doses, it stimulates the appetite, improves body strength, 
removes neurasthenia, reduces fever. It also stimulates the heart, lung, bowels and 
reproductive organs; improves the resistance to infections. It is generally used in Unani 
medicine for its reproductive function. 
Actions:  
REVIEW OF LITERATURE 
 
ANTI-CANCER ACTIVITY OF ASHTA BAIRAVA CHENDURAM |  29 
 
               Appetizer, Tonic, Nervine Tonic, Antipyretic 
General properties: 
 ―க஬ள்ரபப்தொ டொ஠ம் ஬ிடங் டி஡ீ பேம்பூசக் 
       க ொள்ரபச் சு஧ப஡ொ஭ங் ப ொ஧சந்஢ி – க஡ொள்ரபப௅று 
       ஢ொசிப்புண் ஬ொய்ப்புண் ஢ரண ி஧ந்஡ி பதொப௃ண்஠ 
       ஆசிக்கு கும்தப௃ரன ஆய்.” 
                              -த஡ொர்த்஡ கு஠ சிந்஡ொ஥஠ி .  
              It has been found to be effective in the treatment of epidemic fever, poison bite, 
delirium, infections and ulcer of the nose and mouth venereal ulcers, filarial fever, skin 
diseases and asthma. Its dosage is 4-8 mg.  
Method of purification: 
             Arsenic trioxide 35 gm is powdered and triturated with lemon juice. It is made in to 
small cakes and dried. This process is repeated for 7 times. 
Toxic symptoms of Arsenic trioxide: 
 Acute poisoning:  
              Blister, ulcer, pain in the hands and legs finger, swelling of the face, ulcer of the 
upper lip, vomiting and bad odor, tastelessness,  sore throat burning sensation in the stomach, 
bleeding diarrhea and vomiting, hemetemesis, excessive sweating, thirst, strangury, syncope, 
convulsion, loss of memory and anasarca. 
Chronic poisoning: 
 Pruritus, eczema, chronic hepatitis, indigestion, swelling of the face, pain in the 
throat, gastritis, giddiness and diarrhea. 
Antidote:  
 Cardamom and root of Bryonia Scabrella (4.2 gm each) are taken and decoction is 
made with sugar and Alum. It is taken twice a day for 40 days. 
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 If Pitha exceeds with vomiting, give decoction. 
 Give pepper paste for curing the Arsenic trioxide poisoning. 
 The Kalkam of the Indigo plant root can also be used in Arsenic poisoning, as twice a 
day 
[23H]
. 
MODERN ASPECT OF WHITE ARSENIC: 
Arsenic trioxide    -     As3+      O2− 
Systematic name  -  Diarsenic trioxide 
Other names    -   Arsenic (III) oxide, Arsenic sesquioxide 
Properties: 
Appearance       -    White solid 
Molecular formula     -   As 
Molar mass       - 197.841 g/mol 
Density     - 3.74 g/cm3 
Melting point     - 312.2 °C; 594.0 °F; 585.3 K 
Boiling point       - 465 °C; 869 °F; 738 K 
Solubility in water         -    20 g/L (25 °C) 
Acidity (pKa)     -   9.2 
Chemical properties: 
Formula                        -          As2O3 
Molar mass    -   197.841 g/mol 
Density    -   3.74 g/cm³ 
Melting point    -   312.2 °C 
Boiling point              -   465 °C 
Medicinal uses: 
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In Chinese medicine, Arsenic is known as Pi Shuang and is still used to treat Cancer and 
other degenerative diseases. In Homeopathy, it is called Arsenicum album. 
[37]
 
Arsenic trioxide is a chemotherapeutic agent used to treat leukemia. It is assumed that 
Arsenic trioxide induces Cancer cells to undergo apoptosis. It is used as a cytostatic in the 
treatment of acute myeloid leukemia. The combination therapy of Arsenic trioxide and all-
trans Retinoic acid (ATRA) has been approved by the U.S.A. Food and Drug Administration 
(FDA) for treatment of certain leukemias. University of Hong Kong developed a liquid form 
of Arsenic trioxide that can be administered orally.  
Toxic effects: 
 Toxic effects are also well known upon inhalation or upon contact to skin. Symptoms of 
Arsenic poisoning are vomiting, abdominal pains, diarrhea sometimes with bleeding, 
convulsions, paralysis, cardiovascular problems, anaemia, inflammation of the liver and 
kidneys. These are followed by the appearance of characteristic white lines (Mees stripes) on 
the nails and by hair loss.  
Chronic Arsenic poisoning is called as Arsenicosis. It affects workers in smelters, in 
populations whose taking water contains high levels of Arsenic (0.3–0.4 ppm), and in patients 
treated for long time with Arsenic-based medicines
[38]
. 
 
SIDDHA ASPECT OFKUPPAIMENI (Acalypha indica): 
 
Other names:    
 Arimanjari, Poonai vananki, Meni 
Vernacular names: 
English name   –  Indian Acalypha, cat‘s struggle 
Sanskrit name  –  Arittamanjarie 
Telugu name   –  Kuppi-chette 
Malayala  name  –  Kuppamani 
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Kannada name  –  Kuppigida 
Parts used – Leaf, root, whole plant. 
Taste – Bitter, Pungent, Potency – Hot, Division – Pungent  
Habitat: 
              A small shrub found all over India in gardens and roadsides. Its height is about 1-2 
feet. 
General properties: 
“஡ந்஡ப௄ னப்தி஠ி஡ீத் ஡ந்஡ிடுபுண் சர்஬஬ிடம் 
     உந்துகுன்஥ம் ஬ொ஡ம் உ஡ி஧ப௄ – னந்஡ிணவு 
     சூனஞ்சு ஬ொசம் க஡ொடர்த ீசங் தம்பதொம் 
     ஞொனங்க ொள் ப஥ணி஦஡ ணொல் ”. 
-த஡ொர்த்஡ கு஠ சிந்஡ொ஥஠ி . 
It is used in the treatment of tooth canal diseases, burns, stomach pain, vaatha diseases, piles, 
itching, asthma, rhinorrhea and cough. 
Action: 
 Anthelmintic  
 Anodyne 
 Cathartic  
 Diuretic 
 Expectorant [39A] 
BOTANICAL ASPECT OF KUPPAIMENI (Acalypha indica ): 
Taxonomical classification:  
Kingdom            -        Plantae                                
Order                 -    Malpighiales 
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Family      -    Euphorbiaceae 
Genus      -    Acalypha  
Species      -   A. indica 
Binomial name   -      Acalypha indica L 
Habitat: 
                It is an annual herb and about 75 cm in height. Its leaves are 3-8cm long, ovate, thin 
usually 3-nerve, flowers auxiliary erect spikes, female flower supported by conspicuous 
wedge-shaped bracts, male flower: minute.  
Distribution: 
            This species is globally distributed from Tropical Africa to Malaysia. Within India, it 
occurs throughout the plains. 
Vernacular names: 
English name    -    Indian Acalypha, three-seeded Mercury, Indian nettle 
Ayurvedic name   -   Kuppi, Haritamanjari, Muktavarchaa 
Pharmacognacy: 
          Whole plant contains alkaloid ‗Acalyphin‘. Its root contains a Cyanogenetic glucoside 
and Triacetonamine. This glucoside crystallises in two forms, thin hexagonal plants 
(m.p.,182-4ᵒ) and fine silky needles (m.p.,108ᵒ). Stigmasterol isolated from roots and leaves; 
Acalyphol acetate isolated only from leaves.  
Action: 
          Leaf     -  Antibacterial  
         Whole Plant   -    emetic, expectorant. 
[40]
 
Medicinal uses: 
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           Leaves used in the treatment of scabies, bronchitis, asthma, pneumonia. Tincture of 
fresh plant is used in Homeopathy for incipient phthisis with bloody expectorations, 
emaciation and arterial haemorrhage.
[41]
 
SIDDHA ASPECT OF VETRILAI(Piper betle): 
Other names: 
Thaampoolam, thaampoolavalli, thiraiyal, nagavalli, mellilai, vellilai, melladagu 
Vernacular names: 
English name   -  Betal leaf 
Sanskrit name  -  Nagavalli 
Telugu name  - Tamalapaku 
Kannada name  -  Vilayadele 
Malayala name  - Vetilla  
Habitat: 
           It is a climber, cultivated in tropical places. 
Parts used – Leaves; Taste –Pungent; Potency – hot; Division – Pungent 
General properties: 
 “ஐ஦ம் அறுங் ொண் அ஡ன்சொ஧ங் க ொண்டக் ொற் 
  ரத஦ச் ச஦ித்஡ி஦ம்பதொம் ரதந்க஡ொடிப஦ – க஥ய்஦ின் 
 டி஦ின்கு஠ம்பதொகுங் ொ஧க஬ற்நிரனக்குப் 
தடிப௅ப௃த் ப஡ொட஥ிர஡ப் தொர் ”. 
                              -த஡ொர்த்஡ கு஠ சிந்஡ொ஥஠ி .  
       It is effectivein the treatment of kapha diseases, urticaria, diseases of Tridosa, cough and 
hoarseness of voice. 
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Actions: 
 Stomachic 
 Antiseptic 
 Aphrodisiac 
 Astringent 
 Carminative 
 Stimulant 
 Sialogogue 
 Galactogogue 
 Febrifuge [39B] 
BOTANICAL ASPECTOF VETRILAI (Piper betle): 
Taxonomical classification: 
Kingdom       -   Plantae 
Order       -   Piperales 
Family       -   Piperaceae 
Genus      -         Piper  
Species       -   P. betle 
Binomial name   -   Piper betle L 
Habitat and distribution: 
           Betal plant is a very popular plant in Indonesia and originated from South and South 
East Asia. These plants grow vines or leaning on another tree. The length  of the Betel leaf is 
about 5-8 cm wide and 2-5 cm and bright green in colour. 
Vernacular names: 
      English    -   Betel pepper. 
      Ayurvedic     -  Taambula, Naagvallari, Taambulvalli, Saptashiraa 
      Unani     -   Paan, Tambool 
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Nutritional composition: 
          Water - 85-90%, Carbohydrate - 0.5-6.10%,  Protein - 3-3.5%,  Fat - 0.4-1.0%,  
Minerals   -   2.3-3.3%,  Fibre - 2.3%, Vitamin A - 1.9-2.9 mg/100g,  Vitamin C - 0.005-
0.01%,  Chlorophyll - 0.01-0.25%, Nicotinic acid - 0.63-0.89 mg/100g, Calcium - 0.2-0.5%, 
Potassium - 1.1-4.6%, Thiamine - 10-70μ g/100g, Phosphorus - 0.05-0.6%, Iodine - 3.4 μ 
g/100g, Riboflavin - 1.9-30μg/100g, Nitrogen - 2.0-7.0%, Tannin - 0.1-1.3%, Iron - 0.005-
0.007%. 
Phytochemicals: 
Chavibetol (53.1%), Chavibetol Acetate (15.5%), Caryophyllene (3.79%), Allyl Pyrocatechol 
Diacetate (0.71%), Camphene (0.48%), Chavibetol Methyl Ether (0.48%), Eugenol (0.32%), 
α-Pinene (0.21%), α-limonene (0.14%), Safrole (0.11%), 1,8-cineole (0.04%), p-cymene 
(0.11%) and Allylpyrocatechol Monoacetate determined in leaf oil. 
Action: 
Leaf        — stimulant, astringent, antiseptic 
         Essential oil from leaves    — antispasmodic, antiseptic  
         Fruit       —   bechic [42] 
Medicinal properties: 
        Administration of the leaf extract resulted in decreased tumour burden and tumour 
incidence and a delay in the onset of mammary tumour in Wister rats. The alcoholic extract 
of the leaf is found to show antispermatogenic and antiandrogenic effect in animal study. In 
Ayurveda, betel is used to cure worms. Chewing areca nut and betel leaf is a remedy for bad 
breath. 
[43]
 
SIDDHA ASPECT OF PARUTHI (Gossypium herbaceum): 
Other names: 
Aachatha nabalai, pari, uthuri, kaarpasam, pannal 
Vernacular names: 
English name   –  Indian cotton plant, Common cotton 
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Sanskrit name   –  Karpasa 
Telugu name   –  Paratti 
Kannada name  –  Hatti 
Hindi name   –  Kapas 
Malayala name –  Parithi 
Habitat: 
          It is an annual shrub and is cultivated in India and Srilanka. There are two varieties of 
cotton plant, red cotton and white cotton, red cotton is used for medicine. 
Parts used – Leaf, flower, seed, bark, root bark 
Taste – Astringent, sweet; Potency – Hot; Division- Pungent  
General properties: 
“தபேத்஡ி஦ிரன க஥ொக் ி஧ண்ரடப் தொனினர஧த் துண்஠ 
     ஬பேத்து ின்ந ப஥ க஥ல்னொம் ஥ொறும் – தபேத்஡ 
     ஬ி஧த்஡தித்஡த் ப஡ொடு ஬ி஧஠஬கீ்  ம்பதொம் 
     அ஧த்஡஬ி஡ழ் ஥ொப஡ ஦ரந”. 
 -த஡ொர்த்஡ கு஠ சிந்஡ொ஥஠ி. 
      It is used in the treatment of leucorrhoea, hypertension, ulcer, swelling, piles, dysentery, 
chronic wound and epistaxis.   
Actions: 
 Astringent  
 Tonic [39C] 
BOTANICAL ASPECT OF PARUTHI (Gossypium herbaceum): 
Taxonomical classification: 
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Kingdom       -    Plantae 
Order        -    Malvales 
Family       -   Malvaceae 
Genus       -    Gossypium 
Species      -    G. herbaceum 
Binomial name   -    Gossypium herbaceum L 
Habitat and distribution: 
         It is a small shrub, cultivated mainly in Maharashtra, Tamil Nadu, Andhra Pradesh and 
Karnataka. 
Vernacular names: 
 English name    -         Asiatic Cotton, Levant Cotton, Uppam Cotton 
Ayurvedic name    -  Kaarpaasa, Kaarpaasi, Kaarpaasaka, Kaarpaasa 
Unani name    -    Pambahdaanaa 
Siddha name                 -         Paruthi                                                                                                                                         
Phytochemicals: 
            The seed contains 21.3- 25.2% protein and 0.82-1.96% free Gossypol. The germ of 
the plant contains both Betaine and Choline. The flowers yield a glucosidal pigment, 
Gossypetin. 
Action: 
              Root Bark  - Diuretic, Oxytocic  
Bark  -  Emmenagogue, Haemostatic. 
            Seed  - Demulcent, Laxative, Expectorant, Abortifacient 
[44]
 
Medicinal properties: 
              Cotton seed is used to treat dysmenorrhoea and metrorrhagia and also used to expel 
placenta after birth and to increase lactation. It is used for gastrointestinal complaints such as 
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hemorrhages, nausea, and diarrhoea, as well as fevers and headaches. Cotton seed extract also 
has a potential use as a male contraceptive. In lab rat studies, it has been proved to stop early 
pregnancies. The Ayurvedic Pharmacopoeia of India recommends the seed oil for toning up 
the breast. 
         Ethyl ether and ethanol extracts of Gossypium herbaceum significantly decreased the 
blood glucose level. It not only lowers TC, TGL, LDL, VLDL levels but also increases   the 
level of HDL, Therefore, it has potential role to prevent formation of atherosclerosis and 
coronary heart disease. 
[45]
 
SIDDHA ASPECT OF VELLARUGU (Enicostemma axillare): 
Other name - Vallari 
Habitat: 
          It is a shrub and growing in tropical countries. 
Parts used – whole plant; Taste – Bitter; Potency – Hot; Division– Pungent.  
General properties: 
“குன்஥஥க஥ொடு ஬ொய்வு குடல்஬ொ஡ம் சூரன஦ிர஬ 
 கசன்஥ம்஬ிட் படொடிச் சிர஡ப௅ங் ொண் – ஬ன்ப௃ரன஦ொய் 
 உள்ல௃று ி ஧ந்஡ிகசொநி க஦ொட்டி஦ சிநங்கு஥றும் 
க஬ள்பறுகு ஡ன்ரண ஬ிபேம்பு”.  
            It is efficient in the treatment of ulcer, intestinal diseases, throbbing pain, vaatha 
diseases, joint pain, abscess, itching, scabies, and leucorrhoea and skin diseases. 
Actions: 
 Tonic 
 Stomachic 
 Alternative 
 Laxative 
 Febrifuge [39D] 
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BOTANICAL ASPECT OF VELLARUGU (Enicostemma axillare):                                                                                
Taxonomical classification: 
Family       -     Gentianaceae (Gentian family) 
Genus       -   Enicostema 
Botanical name   -    Enicostema axillare 
Synonyms: 
Enicostemma littorale auct non-Bl, E. hyssopifolium (Willd), E. axillare (Lam.) Raynal 
Habitat and Distribution:        
          Indian Whitehead is a perennial herb growing up to 40 cm tall. Leaves are narrow-
oblong, lance shaped. White flowers are borne in dense clusters in leaf axils. It is globally 
distributed in West Indies, India and Sri Lanka. It is distributed almost all over India up to an 
altitude of about 450 m. 
Vernacular names: 
English name    -   Indian Gentian 
Ayurvedic name   -   Naagjhvaa, Maamajjaka, Naahi, Tikshnapatra 
Unani name    -    Naai, Naahi 
Siddha/Tamil   -   Vellargu. 
Pharmacognosy: 
           Whole plant contain alkaloids; Gentianine, Erythrocentaurin, Enicoflavine and 
Gentiocrucine; Flavonoids—Apigenin, Genkwanin Iso-vitaxin, Swertisin, Saponarin and O-
Glucoside derivatives of Sylwertisin and Isoswertisin; glucosides—Swertiamarin, Triterpene 
betulin. 
Action: 
 Bitter 
 Tonic 
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 Stimulant 
 Blood Purifier 
 Anti-rheumatic 
 Anti-Inflammatory  
 Anthelmintic 
 Cardiostimulant [46] 
Medicinal properties: 
          The whole plant of Indian Whitehead is helpful in the treatment of diabetes, joint pain, 
rheumatism, abdominal ulcers, dermatitis, swelling, malaria and insect poisoning.  
          This plant is used as a substitute for Swertia chirayita, and it is found to be effective 
against malaria. It contains Ophelic acid which is also present in Chiretta. The root extract 
showed antimalarial activity both in vitro and in vivo
[47]
. 
SIDDHA ASPECT OF THULASI (Ocimum sanctum): 
Other names: 
Ari, Ramathulasi, Krishna thulasi, Thiruthulai, Thulavu, Kullai, Vanam, Viruntham, Thuzhai, 
Maalalangal  
Vernacular names: 
English names   -   Holy basil, sacred basil 
Sanskrit name  –  Sami 
Telugu name   –  Thulasi 
Hindi name   – Sami 
Malayala name   –  Thulasi 
Habitat: 
          It is an aromatic shrub growing throughout the country. It grows up to 2-3 feet height, 
there are several varieties in Thulasi like  Nalthulasi, Karunthulasi, Naai thulasi, Nila thulasi, 
Kal  thulasi and  Mul thulasi. 
Parts used – leaf, seed. 
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Taste - Pungent; Potency – Hot; Division – Pungent 
General properties: 
 “பதொனொட்டி ஬ித்து஡ி஧ப் புண்தணீி சப்தி஠ிர஦ 
ப஥னொட்டி ஬ித்து ஬ிபங்குப஥ – சொன 
     ஬பேந்து ப௃டற்குக஬ப்பு ஬ொ஧ொக஥ பனொட்டும் 
     திபேந்஡ர஥ப்த ஦ித்஡ி஦த்ர஡ப் பதய் ”.  
        It is used in the treatment of sinusitis, psychiatric disorder, headache, rhinorrhoea, 
sneezing, fever and kapha diseases. 
Actions: 
 Expectorant 
 Stimulant  
 Diaphoretic [39E] 
 
 
 
 
MODERN ASPECT OF THULASI (Ocimum sanctum): 
Taxonomical classification: 
Kingdom       -  Plantae 
Order                 -   Lamiales 
Family                -     Lamiaceae 
Genus        -   Ocimum  
Species      -   O. tenuiflorum 
Binomial name   -    Ocimum tenuiflorum  or  Ocimum sanctum L. 
Habitat and distribution: 
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Ocimum sanctum is an aromatic plant which is native to the Indian Subcontinent and 
widespread as a cultivated plant throughout the Southeast Asian tropics. It is an erect, much 
branched subshrub, 30–60 cm tall with hairy stems and simple opposite green or purple 
leaves that are strongly scented. The flowers are purplish in elongate racemes in close whorls.  
The two main morphotypes cultivated in India and Nepal are green-leaved (Sri or Lakshmi 
Tulasi) and purple-leaved (Krishna Tulasi) 
Vernacular names: 
English names  -   Holy Basil, Sacred Basil 
Ayurvedic names  -   Tulasi, Surasaa, Surasa, Bhuutaghni, Suravalli,                      
                                                Bahumanjari, Deva dundubhi, Apet-raakshasi               
Unani name    -    Tulasi 
Phytochemistry: 
 Leaves and flowers contain 0.075 and 0.095% of volatile oil respectively.  Major 
components of the essential oil are Eugenol, Carvacrol, Nerol and Eugenolmethylether. 
Leaves have been reported to contain Ursolic acid, Apigenin, Luteolin, Apigenin-7-O-
Glucuronide, Luteolin-7-O-glucuronide, Orientin and Molludistin. β-Caryophyllne, Eugenol 
and Humulene are detected in flower oil. Leaves afforded β-carotene and Ursolic acid; 
determination of Caryophyllene, Bornyl acetate and Eugenol in essential oil. 
Nutrition value: 
           Contains vitamin C and A, and minerals like [9] Calcium, Zinc and Iron, as well as 
chlorophyll and many other phytonutrients. Also enhances the efficient digestion, absorption 
and use of nutrients from food and other herbs. Protein: 30 Kcal, 4.2 g; Fat: 0.5 g; 
Carbohydrate 2.3 g; Calcium: 25 mg; Phosphorus 287 mg; Iron: 15.1 mg and edible portion 
25 mg vitamin C per 100 g. 
Anticancer effect of Ocimum: 
Fresh leaf paste (topically) aqueous and ethanolic extract (orally) for their chemopreventive 
activity against 7, 12-dimethylbenzaanthracene (DMBA) induced (0.5%) hamster buccal 
pouch carcinogenesis. Incidence of papillomas and squamous cell carcinomas were 
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significantly reduced and increased the survival rate in the topically applied leaf paste and 
orally administered extracts to animals. Histopathological observation made on the mucosa 
confirmed the profound effect of the orally administered aqueous extract than other. 
Action: 
Leaf    -  carminative, stomachic, antispasmodic, antiasthmatic                                                          
           Seed  - used in genitourinary diseases 
           Root  - antimalarial 
           Plant  - adaptogenic, antistress 
           Essential oil - antibacterial, antifungal 
[48]
 
Medicinal uses: 
         The leaf of this plant used in the treatment of rhinitis, asthma, bronchitis, ulcers, liver 
diseases and influenza; the seed in psychological disorders, including fear-psychosis and 
obsessions
[49]
. 
3.3. PHARMACEUTICAL REVIEW: 
Chenduram: 
Definition: 
Chenduram is a category of medicines made from metals or minerals (Arsenicals or 
Mercurials or salts) by grinding them with specified juices or distillates or extracts and 
subjecting them to a process of sublimation or calcination or burning or frying or exposing to 
insolation till the characteristic reddening of the product takes place. The Chendooram are 
said to retain their potency for 75 years. 
Method of preparation: 
           Usually two methods of preparation are adopted in their processing though there are 
some exceptions and variants.  
          1. Sublimation by the sand – bath process          
          2. Calcination. 
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1. Sublimation by the sand - bath process (Kuppi Erippu): 
          If the chendooram has Sulphur and Mercury as its components, Sulphur is ground to a 
fine powder in the mortar and grinding should be continued with the addition of the given 
quantity of Mercury, till a black impalpable mobile powder is obtained. Only after this, the 
other ingredients are to be added. 
        In the conventional set up of the sand –bath sublimation contrivance, a heat resistant 
glass flask with a long neck is used as the container for the drug ingredients. Ceramic ware 
had also been in use. Before being put to use, these container are wound around with clay 
smeared cloth ribbons so as to give seven superimposed layers, leaving open the mouth of the 
flask. The flask thus encased should be kept for perfect drying of the covering. 
        It has been found in recent times that one could make use of the enameled Iron bowls 
instead of glass flasks.  
        When using enameled Iron bowls, two identical bowls of appropriate dimensions and 
capacity should be selected and checked for neat contact of rims when juxtaposed. Then 
small holes should be punched along the margins so that the two bowls could be fastened 
with a bonding wire (metallic). Then a perforation is made in the centre of the bottom of one 
of the bowls. Having prepared the bowls thus, they should be secured and bound by pasting 
the binding wire through the marginal holes. This would produce a capsule with a top orifice. 
Clay smeared cloth tape is wound around as would be done for the glass flask, leaving the 
central opening uncovered. This opening is the one through which the reaction going on 
inside is inspected by inserting a probe. 
        The sand – bath is set up by taking a wide earthern trough and spreading fine gravel or 
coarse sand at the bottom to a depth of two centimetres. 
         The capsule into which the drug ingredients are put is placed on the gravel or sand and 
is properly centered. Then the sides packed with sands, leaving the top two centimetres 
unpacked and exposing the capsule. When using glass flasks, the neck should be just out of 
the sand. This setup is placed on the oven and heat is applied, by burning fire wood. 
         In the application of heat, there gradations are recognized. These three stages, mild, 
moderate and intense are best understood and mastered with some experience. 
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         It is said that, if the flames are convergent and resemble a single tongue of flame as in a 
lamp, it is mild fire (Deepakkini). If several such tongues of flame lick the vessel and diverge 
like the flower of lotus, it is moderate (Kamalakkini). If the multiple tongues of flame fill the 
oven and enrich the sand bath. It is the intense stage of fire (Katakkini). 
        These stages of fire should be manipulated and followed as prescribed in the method of 
preparation. In general, the heating is spread over three continuous days. In such cases, mild, 
moderate and intense stages are maintained for 24 hours each, in that order of succession. 
        According to the composition and amount of Sulphur in the preparation, the mixture of 
drugs placed in the capsule will start melting sooner or later. Sulphur starts escaping first in 
the form of yellow vapour through the opening. Later it will start burning sending out a jet of 
blue flame. Just when the blue flame goes out if a long probe of steel wire is inserted into the 
orifice and drawn out the portion that enters the container will show a whitish coating. If the 
Sulphur is still present and not totally burnt out, the probe will have a black sticky coat, when 
there is no blackening of the probe and when whitish coat indicating should be closed and 
heating continued for one or two hours and then the heat withdrawn and the setup is allowed 
to cool by itself. 
        When the setup has cooled down, the capsule containing the medicine is taken out and 
the clay tape winding cut out. The material that has sublimed in upper bowl is gently tapped 
with suitable beater or lifted with a spatula. The sublimate collected should be finely ground 
in a mortar. 
         If the glass flasks had been used, the flask is carefully broken, open to collect the 
medicine that has sublimed in around the neck.     
2. Calcination (Putam): 
         The powder is ground in a Kalvam with specified fluids for a specified time. The paste 
is made into small discs and dried. They are put in earthern saucers (man agal) covered with 
another and the edge well sealed with mud cloth. It is allowed to dry. The cups are placed in 
the middle of cow – dung cakes and burnt. For Putams, generally pits of various depths and 
circumferences are made in the ground. Half of the pit is covered with cow – dung cakes. The 
earthern cups are placed and it is covered again with cow-dung cakes. The fire is put in the 
middle of the heap on all the four sides so that there would be uniform heat from all the sides. 
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        All the metals and other ingredients are taken after the usual purification. In specified 
cases, specific purification (Suddhi) is mentioned; otherwise, it is to be taken as general 
method of purification for the drug as mentioned in Materia- Medica books. 
Other methods of preparations: 
        1. Prepared without heating (Araippu Chendooram) 
        2. Prepared by open heating (Erippu or Varuppu Chendooram) 
        3. Prepared by applying heat in the range close to 100◦c (Lagu Puda Chendooram) [50]. 
3.3PHARMACOLOGICAL REVIEW  
 
SIDDHA ASPECT OF THE DISEASE: 
Hippocrates (ca. 460 BC – ca. 370 BC) described several kinds of Cancer, referring to them 
with the Greek word Karkinos (Crab or Crayfish). This name comes from the appearance of 
the cut surface of a solid malignant tumour, with "the veins stretched on all sides as the 
animal the crab has its feet, whence it derives its name"
[51]
. In Siddha system of medicine, 
Cancer is referred to Vippuruthi or Putru.  
“புற்று ப஢ொர஦ க஥ௌணப்தர ஬ன் 
஥ரநந்஡ிபேந்து க ொல்லூம் தர ஬ன்”.  
 -஡ிபே஥ந்஡ி஧ம் 
Generally, a chronic tumour or swelling or ulcer is first identification of Putru in Siddha 
system. Tumours grow gradually and finally look like a Putruor cauliflower. 
Causes: 
 Taking excessive amount of salt and pungent. 
 Taking large quantity of fish and meat. 
 Making sleep in day time. 
Types of Vippuruthi:             
Vippuruthi is classified into seven types, 
1. Karppa Vippuruthi 
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2. Kuvalai Vippuruthi 
3. Vatha Vippuruthi 
4. Pitha Vippuruthi 
5. Seththuma Vippuruthi 
6. Santhu Vippuruthi 
 7. Oodu Vippuruthi 
 Karppa Vippuruthi: 
 Gastric regurgitation 
 pain in side and lower abdomen 
 dryness of  skin 
 lower abdominal swelling like pregnancy 
 head ache 
 Kuvalai Vippuruthi: 
 Pain in lower back, anal region and side of the chest 
 Fever with shivering 
 Cough with expectoration 
 Abdominal pain and swelling 
 Vatha Vippuruthi:  
 Pain and swelling in the lower abdomen, this swelling looks like a frog 
 Fever 
 Wound in the abdomen 
 Pus discharge from the wound and abdominal distension 
 Pitha Vippuruthi: 
 Hematemesis 
 Paleness of the skin 
 Burning sensation all over the body 
 Shivering 
 Mental disorder 
 Hiccup 
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 Tastelessness of the tongue 
 Fever 
 Dehydration 
 Hematoma and abdominal pain 
 Sethuma Vippuruthi: 
          Small tumour and abscess in the abdomen, abdominal pain, fever, cough and swelling 
of the body. 
 Santhu Vippuruthi: 
          Swelling in the side of the abdomen, this swelling is characterized by  
 Shining 
 Hardness 
 cool and itching 
 Oodu Vippuruthi: 
 Fever 
 Blackish discolouration of skin 
 Abdominal pain 
 Giddiness 
 Vomiting 
 Diarrhoea and body pain.   
 
Curable type of Vippuruthi: 
          1. Karpa Vippuruthi 
          2. Kuvalai Vippuruthi  
          3. Pitha Vippuruthi 
          4. Oodu Vippuruthi 
Incurable type of Vippuruthi: 
1. Santhu Vippuruthi 
          2. Sethuma Vippuruthi 
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          3. Vatha Vippuruthi. 
[52]
 
3.2.2. MODERN ASPECT OF THE DISEASE:           
Cancer: 
        Cancer known medically as malignant neoplasia, is a broad group of diseases involving 
unregulated cell growth. In Cancer, cells divide and grow uncontrollably, forming malignant 
tumours, which may invade nearby parts of the body. The Cancer may also spread to more 
distant parts of the body through the lymphatic system or bloodstream. Not all tumours are 
Cancerous; benign tumours do not invade neighbouring tissues and do not spread throughout 
the body. There are over 200 different known Cancers that affect humans. 
History: 
Cancer has existed for all of human history. The earliest written record regarding Cancer is 
from circa 1600 BC in the Egyptian Edwin Smith Papyrus and describes Cancer of the breast. 
Hippocrates (ca. 460 BC – ca. 370 BC) described several kinds of Cancer, referring to them 
with the Greek word Karkinos (Crab or Crayfish). This name comes from the appearance of 
the cut surface of a solid malignant tumour, with "the veins stretched on all sides as the 
animal the crab has its feet, whence it derives its name." Galen stated that "Cancer of the 
breast is so called because of the fancied resemblance to a crab given by the lateral 
prolongations of the tumour and the adjacent distended veins". Celsus (ca. 25 BC – 50 AD) 
translated Karkinos into the Latin Cancer, also meaning crab and recommended surgery as 
treatment. Galen (2nd century AD) disagreed with the use of surgery and recommended 
purgatives instead. These recommendations largely stood for 1000 years. 
In the 15th, 16th and 17th centuries, it became acceptable for doctors to dissect bodies to 
discover the cause of death. The German professor Wilhelm Fabry believed that breast 
Cancer was caused by a milk clot in a mammary duct. The Dutch professor Francois de la 
Boe Sylvius, a follower of Descartes, believed that all disease was the outcome of chemical 
processes, and that acidic lymph fluid was the cause of Cancer. His contemporary Nicolaes 
Tulp believed that Cancer was a poison that slowly spreads, and concluded that it was 
contagious. 
The physician John Hill described tobacco snuff as the cause of nose Cancer in 1761. This 
was followed by the report in 1775 by British surgeon Percivall Pott that Cancer of the 
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scrotum was a common disease among chimney sweeps. With the widespread use of the 
microscope in the 18th century, it was discovered that the 'Cancer poison' spread from the 
primary tumor through the lymph nodes to other sites ("metastasis"). This view of the disease 
was first formulated by the English surgeon Campbell De Morgan between 1871 and 1874
[53].
 
  Epidemiology of Cancer: 
         Nearly seven lakh Indians die of Cancer every year, while over 10 lakh are newly 
diagnosed with some form of the disease. According to the latest World Cancer Report from 
the World Health Organisation (WHO), more women in India are being newly diagnosed 
with Cancer annually. As against 4.77 lakh men, 5.37 lakh women were diagnosed with 
Cancer in India in 2012.  
         In terms of Cancer deaths, the mortality rate among men and women in India is almost 
the same. While 3.56 lakh men died of Cancer in 2012 in India, the corresponding number for 
women was 3.26 lakh. One in every 10 Indians runs the risk of getting Cancer before 75 
years of age. 
          Cancer of lip and oral cavity has emerged as the deadliest among Indian men while for 
women, it is breast Cancer. The top five Cancers in men are lip/oral cavity, lung, stomach, 
colorectum and pharynx, while among women they are breast, cervix, colorectum, ovary and 
lip/oral cavity.  
         The global Cancer burden jumped to 14.1 million new cases in 2012, with WHO saying 
the marked increase in breast Cancers must be addressed. The International Agency for 
Research on Cancer (IARC) 2012 estimated 14.1 million new Cancer cases and 8.2 million 
Cancer-related deaths occurred in 2012, compared with 12.7 million and 7.6 million, 
respectively, in 2008.  
         The most commonly diagnosed Cancers worldwide were those of the lung (1.8 million, 
13% of the total), breast (1.7 million, 11.9%), and colorectum (1.4 million, 9.7%). The most 
common causes of Cancer death were Cancers of the lung (1.6 million, 19.4% of the total), 
liver (0.8 million, 9.1%), and stomach (0.7 million, 8.8%).  
         Projections based on IARC 2012 estimates predict a substantive increase to 19.3 million 
new Cancer cases per year by 2025, due to growth and ageing of the global population. More 
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than half of all Cancers (56.8%) and Cancer deaths (64.9%) in 2012 occurred in less 
developed regions of the world, and these proportions will increase further by 2025
[54] .
 
Causes: 
        Cancers are primarily an environmental disease with 90–95% of cases attributed to 
environmental factors and 5–10% due to genetics. Environmental, as used by Cancer 
researchers, means any cause that is not inherited genetically, such as lifestyle, economic and 
behavioural factors, and not merely pollution. Common environmental factors that contribute 
to Cancer death include tobacco (25–30%), diet and obesity (30–35%), infections (15–20%), 
radiation (both ionizing and non-ionizing, up to 10%), stress, lack of physical activity, and 
environmental pollutants. 
          It is nearly impossible to prove what caused a Cancer in any individual, because most 
Cancers have multiple possible causes. For example, if a person who uses tobacco heavily 
develops lung Cancer, then it was probably caused by the tobacco use, but since everyone has 
a small chance of developing lung Cancer as a result of air pollution or radiation, then there is 
a small chance that the Cancer developed because of air pollution or radiation
[55]
. 
Classification of Cancer: 
         There are five broad groups that are used to classify Cancer. 
        1. Carcinomas are characterized by cells that cover internal and external parts of the               
body such as lung, breast, and colon Cancer. 
        2. Sarcomas are characterized by cells that are located in bone, cartilage, fat, connective 
tissue, muscle, and other supportive tissues. 
        3. Lymphomas are Cancers that begin in the lymph nodes and immune system tissues. 
        4. Leukemias are Cancers that begin in the bone marrow and often accumulate in the 
bloodstream. 
        5. Adenomas are Cancers that arise in the thyroid, the pituitary gland, the adrenal gland, 
and other glandular tissues 
[56]
. 
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Metastasis: 
        Metastasis is the spread of Cancer to other locations in the body. The new tumours are 
called metastatic tumours, while the original is called the primary tumour. Almost all Cancers 
can metastasize. Most Cancer deaths are due to Cancer that has spread from its primary site 
to other organs
[57]
. 
Head and neck Cancer: 
          Tumours of the head and neck are the sixth most common malignancy in the world, 
with a yearly incidence of more than 500,000 cases, and it comprises approximately 4% to 
5% of all new Cancers and 2% of all Cancer deaths (100,000 per year). Most patients are 
older than 50 years, and incidence increases with age; the male-to-female ratio is 2.5:1. 
Approximately 34% of oral and pharyngeal Cancers present as localized disease, 46% present 
as loco regional (i.e., locally advanced or involving regional lymph nodes) disease, and 10% 
present as metastatic disease. Ninety percent of these Cancers involve squamous cell 
histology. The most common sites are the oral cavity, pharynx, larynx, and hypopharynx. 
Nasal cavity and paranasal sinus Cancers, salivary gland malignancies, and various sarcomas, 
lymphomas, and melanoma are less common. 
Site-specific head and neck tumours: 
Oral cavity: 
           The oral cavity includes the lip, anterior two thirds of the tongue, floor of the mouth, 
buccal mucosa, gingiva, hard palate, and retromolar trigone. Squamous cell carcinoma is the 
histologic type observed in most cases. 
Oropharynx: 
         The oropharynx includes the base of the tongue, tonsils, posterior pharyngeal wall, and 
the soft palate. 
Larynx: 
         Risk factors are a history of tobacco and/or alcohol intake. In addition, certain dietary 
factors and exposure to wood dust, Nitrogen mustard, asbestos, and nickel have been 
implicated as etiologic factors. The male-to-female ratio for laryngeal Cancer is 4.5:1, with a 
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peak incidence in the sixth decade of life. More than 95% of laryngeal Cancers are squamous 
cell Carcinomas. 
        Laryngeal Cancers can be supraglottic, glottic, and/or subglottic. Early Cancers not 
requiring laryngectomy are usually treated with radiation. If lymph nodes are involved, neck 
dissection and/or neck radiation is indicated. Locally advanced resectable tumors may be 
treated with surgery and adjuvant radiation if loco regional risk factors are present. An 
alternative is the use of combined radiation and chemotherapy.  
Hypopharynx: 
          Early Cancers not requiring laryngectomy can be treated with surgery or radiation. 
Locally advanced resectable tumours may be treated with surgery followed by radiation or 
sequential or concomitant chemoradiation. In these cases, surgery involves total 
laryngectomy and partial or total pharyngectomy and neck dissection.  
Nasal Cavity and Paranasal Sinuses: 
         Most tumours are squamous cell carcinomas and are usually slow growing with low 
incidence of metastasis. Carcinomas of the nasal cavity and paranasal sinuses are usually 
detected in patients in advanced stages because of the relatively silent tumour location. 
Treatment follows the same general guidelines as those for oral Cancer.  
Nasopharynx: 
            It is extremely rare in most parts of the world, with an incidence of less than 1 case 
per 100,000 population. However, it is endemic in certain areas, including North Africa, 
Southeast Asia, China, and the far northern hemisphere. EBV is strongly associated with 
nasopharyngeal Carcinoma. This association has been demonstrated by serologic studies and 
by the detection of the viral genome in tumour samples. Diet (salt-cured fish and meat) and 
genetic susceptibility are other probable risk factors; tobacco and alcohol are not risk factors,  
except in a minority of cases. 
Salivary Gland Cancer: 
Salivary gland Cancers make up about 3% of all head and neck Cancers diagnosed in the 
United States yearly. Tobacco and alcohol consumption are not risk factors, except possibly 
in women. Ionizing radiation and certain occupational exposures (e.g., in workers in rubber 
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and automotive industries, wood workers, and farm workers) have been associated with the 
development of salivary gland Cancer. 
The salivary glands are classified as major (parotid, submandibular, and sublingual) and 
minor (distributed along upper aerodigestive tract, predominantly in the oral and nasal 
cavities and the paranasal sinuses). Most of the salivary gland Cancers arise from the parotid 
glands; sublingual and minor salivary gland Cancers are rare. 
Most salivary gland tumours are benign, and the most common histology is pleomorphic 
adenoma, which is characterized by slow growth and few symptoms, and is most frequently 
seen in the parotid gland. The most common presentation of benign salivary gland tumours is 
asymptomatic swelling of the lip, the parotid, or the submandibular or the sublingual glands. 
Persistent pain or neurologic involvement (mucosal or tongue numbness and facial nerve 
weakness) suggests malignant disease.  
Surgery is the mainstay of treatment for all localized stages of salivary gland tumours. 
Postoperative radiation is indicated for localized tumours of high-grade histology, that are 
large, with close or positive margins, and/or positive regional lymph nodes. Radiation is the 
primary treatment for unresectable tumours. The role of chemotherapy is limited to the 
management of locally recurrent, unresectable disease or distant metastatic disease. There is 
no established standard chemotherapy for salivary gland Cancer. Regimens employing 
Cisplatin, Carboplatin, Anthracyclines, Taxanes, Cyclophosphamide, and 5-FU result in 
transient responses in 14% to 30% 
[58]
. 
Other head and neck tumours: 
Sarcoma: 
Soft tissue sarcomas of the head and neck are relatively rare. Of head and neck sarcomas, 
80% are seen in adults and 20% are in children. These tumours are heterogeneous and can 
present in any head and neck site, commonly as a submucosal or subcutaneous painless mass. 
In the hypopharynx and nasopharynx, the presenting symptoms may be cranial nerve 
abnormalities or airway or swallowing difficulties. As in sarcomas at other sites, grade is an 
important prognostic indicator. High-grade, aggressive tumours such as malignant fibrous 
histiocytoma, angiosarcoma, osteogenic sarcoma, neurofibrosarcoma, and soft part sarcomas 
tend to be locally aggressive and spread along neurovascular structures, fascia, and bone. In 
addition to aggressive local behavior, there is a high risk for metastatic disease, particularly in 
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lung, bone, central nervous system, and liver. Metastatic disease may occur without local 
lymph node involvement. Sarcomas may arise after radiation therapy, but this is very 
uncommon in the head and neck region. The prognosis for these secondary sarcomas may be 
worse than for primary sarcomas. 
Treatment depends on stage, age of the patient, tumour type, location, and size. Wide margin 
en bloc resection is the goal, but may not be possible because of the proximity of vital 
structures. Adjuvant postoperative radiation and/or brachytherapy can improve local control 
in aggressive sarcomas. The major indications for adjuvant radiation are high-grade sarcomas 
or positive margins, lesions greater than 5 cm, and recurrent sarcoma. Elective neck radiation 
is not necessary because the incidence of occult positive lymph nodes is low. Soft tissue and 
possibly osteogenic sarcomas may benefit from adjuvant or neoadjuvant chemoradiation. 
Such patients should be referred to clinical trials when possible. Overall survival rate 
approaches 60% for patients with sarcomas of the head and neck. 
Melanoma: 
Mucosal melanomas represent less than 1.5% of all melanomas. About 50% of mucosal 
melanomas occur in the head and neck, and more than 20% of melanomas that occur in the 
head and neck region are mucosal. The age of diagnosis is 60 to 80 years. The hard palate is 
the most common site. Nearly one-third of these tumours are amelanotic. The proportion of 
mucosal melanomas is higher in African American and Hispanic populations than in white 
populations. Although rare in the United States, mucosal melanomas are more frequent in 
Japan and in some parts of Africa. Mucosal melanomas may be multiple, may have satellite 
lesions, may invade angiolymphatics, and can metastasize. They behave more aggressively 
than skin melanomas. Lymph node metastasis is observed at presentation in up to 48% of 
patients. Surgery is the mainstay of treatment for local or locoregional disease. Prophylactic 
lymph node dissection is not recommended. Radiation, when used, is usually employed 
adjuvantly for positive margins or used palliatively for local recurrence or unresectability. 
Adjuvant use of radiation has not been shown to improve survival. Prophylactic nodal 
radiation is not recommended. Chemotherapy and Immunotherapy have been studied, but the 
effect of these interventions on survival when used as palliation or as adjuvant therapy has 
not been defined. Patients should be encouraged to enter clinical trials where available. Mean 
overall 5-year survival is 17%
[59]
. 
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Oral Cancer:  
           Oral Cancer is one of the most common head and neck malignancies. Oral Cancer is a 
general term for oral cavity Cancers. It occurs in the majority, where squamous cell 
carcinoma, which is called the mucosa mutate. In clinical practice, oral Cancer, including 
Cancer gums , tongue , hard and softpalate, carcinoma of the mandible , oropharynx, lip 
Cancer and maxillary sinus. Cancer occurs in the facial skin and mucous membranes of oral 
cavity and so on.  
 Causes of Oral Cancer:  
 Long-term habit of tobacco, alcohol: 
          Most oral Cancer occurs in patients with long-term history of smoking and drinking.   
Poor oral hygiene: 
Poor oral hygiene, bacteria or fungi in the mouth breeding to create the conditions, thus 
contributing to the formation of Nitrosamines and their precursors. Coupled stomatitis, 
proliferation of some cells in this stage, more sensitive to carcinogens, are the variety of 
reasons which contribute to oral Cancer. 
Long-term stimulation by foreign body: 
Root or sharp cusp, inappropriate dentures long-term stimulation of oral mucosa, resulting in 
chronic ulcers and even Cancer. 
Malnutrition: 
           Vitamin A deficiency can cause oral mucosal epithelial thickening, hyperkeratosis 
with the occurrence of oral Cancer. Demographic studies show that countries with low intake 
of vitamin A high incidence of oral Cancer. There are also inadequate intake of trace 
elements considered relevant, such as low Zinc content of foods. Zinc is indispensable for the 
growth of animal tissue elements, Zinc deficiency may lead to mucosal epithelial damage, 
and create favorable conditions for the occurrence of oral Cancer. Inadequate plant protein 
and animal protein intake may be associated with oral Cancer
[60]. 
Leukoplakia and Erythema: 
Oral Leukoplakia and hypertrophic Erythema often a precancerous lesion. 
Associated lesions: 
            The relationship between oral Cancer and precancerous lesions: 
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            White ulcers or blisters inside the buccal mucosa occurs, often occurs as pressure 
sores, poor sleep or eating habits (such as insufficient fruits), in general will heal within two 
weeks. If it is not cured in two weeks, must be examined to rule out the possibility of 
epithelial cell carcinoma.  
Changes in the oral mucosa color: 
            Normal epithelium pink, red or a white color of polarization are not normal. If red 
with white, it is more serious situation, another example of the tongue appears dark red with 
white dot  like, highly suspicious of Cancer.  
Ulcer: 
            Over more than two weeks of oral mucosal ulcer has not yet healed.  
Clinical manifestations:  
 Lumps, nodules 
 White, smooth scaly plaque appeared  
 Red patches, ulcers, inflammation and other symptoms distinct can‘t be cured             
for a longer  period 
 Repeated oral bleeding for no apparent reason  
 Numbness, burning, or dryness of mouth for no apparent reason  
 Unusual difficulty in speaking or swallowing[61] 
Differential diagnosis 
Traumatic ulcers: 
           These ulcers often occur in the edges of tongue, the corresponding total area of the 
ulcers, or irregular teeth and root dental prosthesis, indicating that ulcers are caused by the 
stimulus. Ulcers are soft with no induration tend to heal in 1or2 weeks if the irritant is 
eliminated.  
Tubercular ulcers: 
         These are almost secondary, mostly open tuberculosis direct result of the spread, often 
occurs in the soft palate, buccal mucosa and back of the tongue, shallow ulcers compared 
with Cancerous ulcer, ulcer base induration soft non-invasive, effective anti-TB treatment. 
Imaging and biopsy can accurately identify and diagnose. 
Diagnosis: 
When neck mass is the first presentation, the primary site can be located and biopsied in 
approximately 80% of cases. If no primary site is obvious, tissue diagnosis can be obtained 
by fine needle aspiration (FNA) biopsy of the node, with sensitivity and specificity 
approaching 99%. A non-diagnostic FNA does not rule out the presence of tumour. 
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Computerized tomography scan (CT scan) remains the primary imaging study for evaluation 
of metastatic adenopathy. Magnetic resonance imaging (MRI) may complement the CT scan. 
Positron emission tomography (PET) scans are being used more frequently to detect tumours 
that are not obvious on other scans.  
Laryngoscopy and nasopharyngoscopy should be performed. With occult primary tumours, 
directed biopsies of the nasopharynx, tonsil, base of tongue, and pyriform sinus should be 
performed. Bilateral tonsillectomy will sometimes reveal the source of an occult Cancer. 
[62]
 
Treatment: 
The management of patients with head and neck Cancer is complex. The choice of treatment 
modality depends on the stage and site of disease. Patients with locally advanced disease 
should be evaluated (prosthodontics, nutrition, speech, and swallowing) by a 
multidisciplinary team including otolaryngologist or head and neck surgical oncologist, 
radiation oncologist, medical oncologist, dentist, and personnel involved in rehabilitation 
before treatment is initiated. 
In general, either surgery or radiation is effective as single-modality therapy for patients with 
early-stage disease (stage I or II) for most sites. The choice of modality depends on local 
expertise, patient preference, and functional result. For the 60% of patients with locally 
advanced disease (stage III, IV, and M0), combined-modality therapy is indicated. 
[63]
 
Surgery 
The nature of the surgical procedure is determined primarily by the size of the tumour and the 
structures involved. Extensive surgeries and those involving function of the tongue. 
Frequently require muocutaneous flaps or microvascular free flaps to achieve a more 
functional reconstruction. 
Resectability depends on the experience of the surgeon and the rehabilitation team. In 
general, a tumour is unresectable if the surgeon believes that all of the gross tumour cannot 
be removed or that local and distant control will not be achieved after surgery even with 
adjuvant radiation therapy. Generally, involvement of the skull base, pterygoid, and deep 
neck musculature, and of the major vessels portends a poor outcome with surgery as a 
primary modality. 
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Cervical lymph node dissections may be elective or therapeutic. Elective neck dissections are 
done at the time of surgery in patients with necks that are clinically negative when the risk of 
a positive lymph node is at least 30%. Therapeutic neck dissections are done for clinically 
obvious masses. This surgery is now rarely performed because of excessive morbidity, 
especially loss of shoulder function. The modified radical dissection preserves one or more of 
the non-lymphatic structures. In selective neck dissections, only certain levels of lymph nodes 
are removed on the basis of the specific lymphatic drainage from the primary site.  
Radiation Therapy: 
The use of radiation as a single therapy in early-stage tumours (i.e., T1 and T2) is as 
efficacious as surgery. The choice of therapy depends on expected quality of life, functional 
outcome, sequelae of therapy, and options for treatment in case of recurrence. 
In locally advanced tumours (i.e., T3 and T4), radiation therapy is combined with surgery. In 
general, postoperative radiation is preferred over preoperative radiation according to the 
results of two randomized prospective studies that show superior local control and minimally 
increased survival in the postoperative radiation arm in hypopharyngeal Cancer patients. 
Postoperative radiotherapy is recommended for patients at high risk for local recurrence [i.e., 
T4 tumour, close or positive margins (<5 mm), perineural or perilymphatic or vascular 
invasion by the tumour, multiple or large positive nodes, and/or extracapsular invasion]. 
The radiation type varies for specific sites and for definitive versus adjuvant therapy. The 
standard fractionation regimen in the United States is 1.8 to 2.0 Gy once daily, 5 days per 
week. The total dose of irradiation for definitive treatment is in the range of 70 to 80 Gy 
depending on the treatment schedule given and on the ability to shield normal tissue.  
Common severe acute radiation toxicity includes epidermitis, mucositis, loss of taste, 
xerostomia, dysphagia, and hair loss. Dental evaluation and necessary extractions should be 
performed before radiation because dental extractions in a radiated mandible can lead to 
osteonecrosis. Dentulous patients should be given prophylactic fluoride. Patients receiving 
radiation are at high risk for tooth decay due to the xerostomia caused by injury to the 
salivary glands as well as mucosal damage.  
Brachytherapy can be used as a definitive treatment for early-stage tumours or combined with 
external beam radiation in more advanced lesions in selected tumours (e.g., tongue, floor of 
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mouth, tonsil, and nasopharynx) with excellent results. Brachytherapy is an option for 
recurrent Cancers of the head and neck, particularly in previously irradiated patients. 
[64]
 
Chemotherapy: 
          Until relatively recently, chemotherapy was used mainly for palliation of patients with 
locally recurrent or disseminated disease without proven survival advantage. Combination 
chemotherapy yields higher response rates but has increased toxicity and no proven survival 
advantage when compared with single agents. The choice of single-agent or combination 
chemotherapy depends on the patient's preference and performance status. Several 
Combination regimens have been developed to improve response rates. The combination of 
Cisplatin and infusional 5-Fluorouracil (5-FU) produces a 70% response rate and a 27% 
complete remission (CR) rate in chemotherapy-naive patients. 
          Platinum-based chemotherapeutic regimens and the single agent methotrexate are the 
most commonly used regimens for metastatic disease. Carboplatin may be slightly less active 
than Cisplatin for head and neck squamous Cancer, but Carboplatin combinations with other 
chemotherapy agents are generally better tolerated than those with Cisplatin. Carboplatin is 
preferred in patients at high risk for Cisplatin toxicity, that is, those with renal dysfunction, 
neuropathy, or hearing loss. 
          Both Docetaxel and Paclitaxel have shown antitumor activity. Several dosing schedules 
for Paclitaxel have been investigated. Three-hour infusions are probably the best balance 
between theoretically optimum exposure and tolerable toxicity. Docetaxel is usually 
administered at doses of 60 to 100 mg per m
2
 every 3 to 4 weeks. 
         The role of chemotherapy has expanded significantly over the last decade because of 
the results of clinical trials incorporating chemotherapy in multimodality regimens for 
previously untreated disease. 
Induction Chemotherapy: 
Induction chemotherapy followed by definitive radiation therapy in patients responding to 
chemotherapy has been studied for organ preservation in patients with locally advanced 
Cancers of the larynx and of the hypopharynx. No significant survival difference has been 
demonstrated for chemotherapy followed by radiotherapy compared to surgery followed by 
radiotherapy in these patients. For laryngeal Cancer, concomitant Cisplatin and radiation 
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therapy leads to better local control. Presently, induction chemotherapy followed by radiation 
therapy can be considered standard only for patients with previously untreated locally 
advanced squamous Cancers in the hypopharynx.  
Concomitant chemoradiation: 
The rationale for concomitant chemoradiation is based on experimental evidence of 
synergism between chemotherapy and radiation that is theoretically mediated by interference 
of chemotherapy with multiple intracellular radiation-induced stress-response pathways 
involved in apoptosis, proliferation, and DNA repair. The finding that certain 
chemotherapeutic agents (e.g., Cisplatin, 5-FU, Taxanes, and Hydroxycarbamide) can induce 
radiosensitivity and increase log cell kill for radiation supports this treatment strategy. 
Cisplatin, the most extensively evaluated drug in recent large randomized trials, has the 
advantage of not having mucositis as toxicity, although as a radiation enhancer, it does 
increase radiation-induced mucositis. 
Adjuvant Chemotherapy: 
A large randomized study in resected patients with stage III or IV disease compared adjuvant 
radiation therapy with adjuvant chemotherapy followed by radiation. This trial showed 
improved local control and overall survival rates approaching statistical significance for a 
subset of patients treated with chemotherapy who were at high risk for local recurrence. 
Patients with low-risk disease did not benefit from adjuvant chemotherapy.  
Adjuvant concomitant cisplatin and radiation in patients at high risk for recurrence after 
surgery has been studied both in Europe and in the United States. Both studies found a 
possible benefit in disease-free or overall survival for patients receiving concomitant cisplatin 
and radiation 
[65]
. 
Prevention:  
1. Avoid unnecessary prolonged illumination, prevent the emergence of lip Cancer  
2. Avoid smoking and drinking 
3. Patients wearing dentures 
a. Found that tissue under dentures pain, inflammation, should seek immediate 
medical attention. Strive to achieve early detection of Cancer, early diagnosis 
and early treatment, and insisted regularly checked.  
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4. Balanced diet 
5. Do not drink and eat hot water and food, to avoid irritation of oral tissues 
6. Unplug the tooth residual root and crown 
7. Good wear dentures, does not stimulate tissue  
8. Develop good oral hygiene habits 
9. Regular brushing. Pay attention to nutritional balance, timely treatment         
Four symptoms of oral Cancer to be alert:   
 If the mouth turns white, brown or black, it means a change in mucosal epithelial cells. 
Especially the oral mucosa becomes rough, thickened or showed induration, appeared oral 
leukoplakia , erythema, is likely to be Cancerous.  
Unhealed ulcer: 
Oral ulcers of the course is generally not more than two weeks, if the burning sensation, pain 
and other symptoms brought the matter still more than two weeks, to be alert to the 
possibility of oral Cancer.  
Obvious pain: 
         Intially generally painless or only partial exception sense of friction, ulceration obvious 
pain, with further violations of the nerve tumor, can cause ear and throat pain.  
Lymph nodes: 
         Multiple oral Cancer to nearby lymph node metastasis to the neck, and sometimes the 
primary lesion is small, and even the symptoms are not obvious, but they found a lymph node 
metastasis of Cancer cells. Therefore, such a sudden neck lymph nodes, need to check the 
mouth.  
Dysfunction: 
          Zhang closed the tumour may infringe muscles and temporomandibular joint, resulting 
in the opening and closing movement is restricted. 
Vaccines: 
       A number of infectious agents cause Cancer. Hepatitis B and C are linked to liver 
Cancer, some human papilloma virus (HPV) strains are linked to cervical and head and neck 
Cancer, and Helicobacter pylori is associated with gastric Cancer and lymphoma. Vaccines to 
protect against these agents may reduce the risk of their associated Cancers. The hepatitis B 
vaccine is effective in preventing hepatitis and hepatomas due to chronic hepatitis B 
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infection. Public health officials are encouraging widespread administration of the hepatitis B 
vaccine, especially in Asia, where the disease is epidemic. A four-valent HPV vaccine 
(Gardasil) is 100% effective at preventing infection. The vaccine is recommended for girls 
and women ages 9–26 years. Reduction in these HPV types could prevent >70% of the 
cervical Cancers worldwide
[66]
. 
3.6 PHARMACOLOGICAL REVIEW OF CANCER: 
The pharmacological screening of plants, minerals and animals is an essential mean for the 
invention of new, harmless, and effective drugs. Over 50,000 plants have therapeutic virtues 
in the world, and around 80% of human use medicines based on plants and salts at least once 
in their life
. 
Medicinal plants and mineral share diversified chemical constituents which are 
important for the discovery of new active molecules against many types of Cancer. Active 
compounds from many medicinal plants and minerals with effective cytotoxic properties 
were developed into AntiCancer drugs. 
Nowadays it has become mandatory to monitor the quality of life of patients while in 
treatment of Cancer. There should be health awareness in the quality of life of Cancer 
patients treated with chemotherapeutic drugs are very much affected even long time after 
withdrawal of drugs. Therefore, the challenging task at this moment is to identify the quick 
and novel methods that can identify and develop molecules, which can be of therapeutic 
value in human Cancers. This urgently necessitates screening of a large number of 
compounds. For this purpose both, the in vitro and in vitro models are employed for 
systematic screening of an AntiCancer drug. 
INVITRO METHODS: 
Though animal models provide more predictable results, in vitro testing is still preferred prior 
to in vivo testing of  a potential chemotherapeutic agent. There are following advantages of in 
vitro models over in vivo models. 
          1. These are less time consuming. 
          2. More cost effective. 
          3. Small quantities and large number of compounds can be tested.  
          4. These are easier to manage. 
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 In addition, in vitro cultures can be cultivated under a controlled environment (pH, 
temperature, humidity, oxygen / Carbon dioxide balance, etc.) resulting in homogenous 
batches of cells and thus minimizing experimental errors. 
 The in vitro methods are not free from disadvantages also and they often furnish false 
positive results (compounds show no activity in vivo) and false negative results (compounds 
shows no activity in vitro but show activity in vivo as they need to be biotransformed in vivo 
to a pharmacologically active compound). A second pitfall is that the role of 
pharmacokinetics in determining drugs effect cannot be evaluated in vitro. In addition, 
geometry of solid tumors in vivo is very different from that of cells growing in vitro in 
suspension or monolayer cultures. 
Ideal Characteristics of an In vitro Screening Method: 
An ideal in vitro screening method should be simple, economical, reproducible, rapid and 
sensitive. The assay should be applicable to large number of tumor types and test compounds. 
The choice of the cell lines should be representative of clinical situation as close as possible. 
The range of drug concentrations used in vitro should be comparable to that expected for in 
vivo treatment. The assay should be able to process a large number of samples quickly and in 
an automated fashion. Data acquisition should be simple, easily interpreted and applied. At 
present no such system is available.  
 The goal of a screening assay is to test the ability of a compound to kill cells, at the 
same time, the assay should be able to discriminate between replicating cells and non 
replicating cells (quiescent cells that are dead or dying apoptosis). Different assays take 
disadvantage of various properties of cells as mentioned below. 
Table: 1. Different assays take disadvantage of various properties of cells 
S.No Cell properties Assay 
1. 
2. 
3. 
 
4. 
5. 
Enzymatic properties 
Protein content/synthesis 
DNA content/synthesis 
 
Membrane integrity 
Clonogenic properties 
Tetrazolium salt assay(MTT) 
Sulphorhodamine B assay 
H-Thymidine uptake Newer fluorescent 
analogues with flow cytometry     
Dye exclusion tests 
Clonogenic assay 
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Tetrazolium Salt Assay (Microculture Tetrazolium Test or MTT): 
MTT assay is an international accepted in vitro method for antiCancer drug screening. 
Though viable cells can be measured using several other staining procedures also but these 
procedures suffer from drawbacks that they require washing steps thereby increasing 
processing time and sample variation. The multiwell plate scanning spectrophotometers can 
quickly measure large number of samples with a high degree precision and accuracy. Ideally, 
a colorimetric assay for living cells utilize a colorless substrate that is modified to a coloured 
product by any living cells, but not by non-viable or dead cells or culture medium. However, 
MTT assay utilizes a color reaction as a measure of viable cells. The assay is dependent on 
the cellular reduction of 3-(4,5-dimethylthaizol-2-yl) -2,5-diphenylltetrazolium bromide, a 
tetrazolium salt to a blue formazan product by the mitochondrial dehydrogenase of viable 
cells/ metabolically active cells. The intensity of blue colored Formanzan produced is directly 
proportional to cell viability. 
 The cells from a particular cell line when in log phase of growth are trypsinized, 
counted in a hemocytometer and adjusted to appropriate density in a suitable medium and 
then inoculated in different multiwell plates (usually 96-well plates). The cells are treated 
with various concentrations (in replicates) of drugs for specified duration (usually 1 to 4 
days), after which MTT dye is added in each well and plates are incubated at 37° for 4 h in a 
co2 incubator. The plates are taken out of incubator and dark blue coloured Formazan crystals 
are thoroughly dissolved in isopropanol / DMSO at a room temperature. The plates are then 
read on an ELISA reader at 570 nm. The percent cell viability with respect to control is 
calculated using the formula: 
                                                   OD of treated cells   
 % Cell viability =   _______________________ × 100 
      OD of control cells  
6. Cell division  Cell counting assay  
 
REVIEW OF LITERATURE 
 
ANTI-CANCER ACTIVITY OF ASHTA BAIRAVA CHENDURAM |  67 
 
 This assay has been successfully used by us. The DMSO as a solvent rapidly 
solubilizes the serum as well as Formazan and use of spectrophotometric grade DMSO gives 
stable "background" absorbance levels. Other solvents like isopropanol, propanol, hexane and 
dimethylformamide though used , do not solubilize serum at concentrations exceeding 0.0625 
percent. 
The advantage of this assay is that it can be run on microtiter dishes on hundreds of 
cell samples at one time so that the various drug concentrations can be used to get an idea of 
the dose response relationship for each drug tested. As a result, this assay can be adopted for 
the determination of  IC50of drugs (concentration of drug required to inhabit 50% cell 
growth). 
 Further this assay is relatively simple and therefore easy to perform. It can be used for 
both adherent and suspension cell lines. This method is cheap, requires low number of cells, 
manageable and a large number of drugs can be quickly screened for antiproliferative 
activity. However, the assay suffers from the drawback of giving false results due to the 
inclusion of cells that might be metabolically active but not capable of dividing 
(nonreplicating). In addition, drugs whose mechanism of section might spare mitochondria 
may not yield positive results in this assay, especially for short incubation times. Also, use of 
DMSO warrants safe handling by laboratory personnel. 
Sulphorhodamine B Assay: 
The Sulphorhodamine B (SRB) assay measures whole-culture protein content, it 
should be proportional to the number of cell. Cell cultures are stained with a protein staining 
dye, Sulphorhodamine B. It is a bright pink dye, which binds to basic amino acids of cells. 
unbound dye is then removed by washing with acetic acid , and protein-bound dye extracted 
using unbuffered. Tris base for determination of optical density in a computer-interfaced, 96-
well microtiter plate reader. Since dead cells either lyse or are lost during the procedure, the 
amount of SRB binding is propotional to the number of live cells left in a culture after drug 
exposure. This assay can be used to measure the cellular protein content of both adherent and 
suspension cultures. Screening capacity, reproducibility and quality control all appear to be 
enhanced in this assay relative to the tetrazolium salt assays. The assay is more cumbersome 
and time consuming compared to the MTT assay. Non-replicating and dead cells might 
contribute to the total protein and interfere with the results. 
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H-thymidine Update Assay: 
  In this assay tumor cell suspensions are exposed to the drug continuously for 5 days, 
after which a radio-labeled precursor (
3
H-thymidine) is added during the final 48 hours of the 
assay to label proliferating cells. The replicating cells will incorporate [
3
H] -thymidine into 
their DNA, which can then be determined either by autoradiography or by liquid scintillation 
counting, Autoradiographic determination of the [3H]-thymidine, though, is time- consuming 
but it provides information on tumor growth kinetics. This can generate DNA histograms, 
which can provide information on the ploidy status of the cells. This assay looks at cells, 
which have actively replicating DNA and hence are viable, Nonreplicating or dead cells will 
not be counted in this case. The assay can be used for both adherent and suspension cell lines. 
The assay is rapid, relatively inexpensive, and feasible in the majority of tumor types. 
However, it will not differentiate between malignant and non malignant cells and might lead 
to false-negative predictions if lethally damaged cells undergo a final division. 
Fluorescence: 
Fluorescent dyes may be used in conjunction with microscopic evaluation methods as 
an in vitro chemosensitivity assay.  Cells are exposed to fluorescent-labeled  precursors after 
drug-exposure. The replicating cells will incorporate labeled precursor into their DNA and 
the resulting fluorescence is then measured by flow cytometry. This assay  also looks at 
actively replicating  cells and hence dead or nonreplicating  cells are not counted. In addition, 
the assay does not involve the use of radioactivity and is useful for adherent and suspension 
cell-lines. Also using flow cytometry it is possible to determine that in what phase of the cell 
cycle the cells are. The quantitation of apoptotic cells is also possible. However this, assay 
requires the data to be analyzed by an expensive and sophisticated fluorescence activated 
cell-sorter(FACS) instrument. Because of  technical difficulties in applying flow cytometry to 
primary  tumor  specimens, data on the predictive value for clinical response  for this assay 
are too scarce to permit definitive conclusions. 
Dye Exclusion Tests: 
Early attempts to use exclusion of vital dyes like trypan blue, eosin, or  nigrosin to 
predict chemosensitivity were unsuccessful. These assays relied on the structural integrity of 
the cells .Dead cells would have lost membrane integrity and hence would take up vital dyes 
like trypan blue. This method was mainly used because of its technical simplicity No 
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prospective trials of these assays have yet been performed , however, to demonstrate their 
ability to predict for response or lack of response. This DISC assay is drug sensitive assay, 
which relies on structural integrity of the cells. In this assay, cells are incubated with drugs 
for 4 days. Dead cells are stained in suspension   with fast green dye with or without nigrosin. 
The  specimen is centrifuged and disks of cells are collected in the microscopic slides. Live 
cells are then stained with hematoxylin-eosin. Duck erythrocytes are used as control. The end 
point of the study is the morphologic identification   of tumor-cell cytotoxicity compared with 
the internal control standard of duck erythrocytes. The DISC assay measures cell kill in both 
dividing and non-dividing and tumor cell population. 
Clonogenic Assays: 
A concern in the use of antiproliferative assays is that they measure growth inhibition 
rather than cell killing. This is particularly important for drugs that act by arresting cells at 
check points in the cells cycle. Checkpoint arrest is a survival response of cells that allows 
repair of DNA damage and is therefore not directly related to the induction of cell death. 
Thus, cells that act by arresting cells at checkpoints may show lower IC50 but increased 
survival. Clonogenic survival assays on the other hand, measure loss of tumor cell 
reproductive viability(the ability of a single cell to form colonies).It is the most direct method 
of measuring cytotoxic activity of a drug, In clonogenic assays single-cell suspension are 
prepared from tumor biopsies and exposed to antiCancer agents to be tested . Cells are then 
rinsed and plated in a semisolid medium (agar or methy1 cellulose),a medium that precludes 
proliferation of nonmalignant cells in the specimen.
15
 After 14 to 28 days, some cells will 
have undergone several divisions and will have formed tumor colonies, which can be 
quantified in a visual or semiautomated fashion. Nonreplicatig and dead cells are not coated 
in this case. The number of colonies from the treated cells is compared with the number of 
colonies from the untreated control cells and the fraction of control growth provides an index 
of drug activity. Traditional clonogenic systems suffer from a number of significant technical 
problems like long incubation time(at least 14 days)before results can be made available to 
the clinician. The assay is labor-intensive, costly, and cannot be used for suspension cell-
lines. 
Cell Counting Assay: 
Cells are cultured in the presence of drug for 2-5 culture-doubling times, after which 
the cell number is estimated using a hemocytometer or a cell counter. The assay is easy to 
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perform, rapid and can be used for both adherent and suspension cell lines. However, dead 
and nonreplicating cells can be counted in this assay by the cell counter. The IC50 values can 
be calculated in all the above assays.         
INVIVO METHODS: 
In vivo models are advantageous over in vitro models in the sense that they detect 
host-mediated activity, are relatively predictable and estimate therapeutic ratio. However, as 
compared with in vitro systems, their sensitivity is low, are costly, time consuming and large 
number of samples cannot be handled and are difficult to manage. After all, animal models 
are used both toxicological studies and for detecting preclinical antiCancer efficacy. They are 
able to detect agents irrespective of their mechanism of action. The drugs with high degree of 
efficacy and broad spectrum of activity in animal models are usually expected to be effective 
in clinical Cancer, however, there are exceptions also which could be due to metabolic 
differences and heterogeneity of Cancer cells between human and rodents. Despite these 
differences animal models are widely used to support the results obtained from in vitro 
studies. The most promising candidate compound is tested in more than one animal model. 
Dose response relationship, combined effect of drugs, modes of their antiCancer action and 
organ specificity are established. Varied drug dosage forms, doses and animal strains and 
animals of a particular age group may be used. The selected animal models should be 
representative of high incidence of humans. The in vivo antiCancer drug screening methods 
are described under the following headings: 
        A. Chemically induced tumor models 
        B. Models involving cell line/tumor pieces implantation. 
Chemically Induced Tumor Models: 
Chemical carcinogens are well-known to account for about 80% of all Cancers and are used 
to induce Cancer in animal models. Carcinogens require metabolic activation before inducing 
carcinogenesis. The epidemiological studies indicate that human carcinogenesis occurs 
through multiple steps in the same way as in mouse skin. The concept of multistep 
carcinogenesis was first of all developed in rodent skin models in 1940s and applies to 
Cancers to many species and cell types. Experimental carcinogenesis involves following 
three steps: 
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 Initiation is due to exposure to carcinogens transforming the normal cell to a Cancer 
cell. 
 promotion is due to the triggering of uncontrolled growth of the transformed cell. 
 Malignant conversion is caused due to unlodging of Cancer cells from the original site 
its transportation by circulation and the establishment of secondary tumors in the 
body. 
The   exact sequence of cellular, biochemical and molecular genetic events may differ 
between tissues and species, the overall concept seems to be directly applicable to clinical 
Cancer and thus in future multistage mouse skin carcinogenesis model will be of immense 
utility for further understanding the mechanisms of epithelial carcinomas in human 
beings.The experiment is well designed; dose of the carcinogen as well as drug treatment 
schedule is standardized by conducting pilot studies. This helps in accurate evaluation of the 
test compound. 
DMBA-induced Mouse Skin Papillomas: 
This is a classical two-stage experimental carcinogenesis model. Mouse skin is 
generally most sensitive to epidermal carcinogenesis, Rats, hamsters and rabbits are less 
sensitive and guinea pig is very resistant 2. SENCAR mice are highly sensitive to DMBA-
induced skin tumors .Swiss albino mice are relatively less susceptible to tumor induction. 
DMBA acts as an initiator and 12-o-tetradecanyl-phorbol-13-acetate(TPA) is used as a 
promotor to induce skin papillomas and squamous cell carcinomas. Mice are topically 
applied a single dose of 2.5µg of TPA in 0.2 ml acetone twice weekly on the same site 
starting one week after DMBA application. Papillomas begin to appear after 6 to 7 weeks of 
application of TPA. Weekly observations are made to monitor tumor development till the 
experiment terminates after 18 weeks. Percent tumor incidence and multiplicity of treatment 
group is compared with DMBA control group. Drug under test can be administrated either 
topically or by oral route. The tumor incidence in this model is usually about 100% in DMBA 
controls. In various laboratories, however, repeated topical application of DMBA alone has 
also been shown to induce carcinogenesis 3. The development of papillomas in DMBA 
treated Swiss albino mouse (24th week). 
 MNU-induced Tracheal Squamous Cell Carcinoma in Hamster: 
In this model, 5% solution of MNU in the normal saline is administrated once a week for 15 
weeks using specially designed catheter, which exposes a defined area of the trachea of male 
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Syrian Golden hamsters to the carcinogen. Fifteen weeks MNU administration produces 
tumors in 40-50% animals within 6 months. Test drug efficacy is measured as percentage 
reduction of tumor incidence compared with carcinogen control. 
DMBA-induced Oral Cancer in Hamster: 
Oral Cancer can be induced in a male Syrian hamsters painting right buccal mucosa, 3 
times/ week for 16 weeks with 0.5% solution of DMBA in liquid paraffin (approximately 10 
µl containing 100 µg). Tumour size, number and tumour burden of drug treated animals can 
be compared with that of control animals at the termination of experiment
[67] 
. 
 
MATERIALS AND METHODS 
 
ANTI -CANCER  ACTIVITY OF ASHTA BAIRAVA CHENDURAM   73 
 
4. MATERIALS AND METHODS 
4.1. PREPARATION OF THE DRUG ASHTA BAIRAVA CHENDOORAM: 
Drug selection: 
In this dissertation, the sample of  AshtaBairavaChendooram was taken as a 
compound drug for Oral Cancerand its preparation were taken from the classical  Siddha 
literature “PranaRakshamirdhaSindhu” Page no:390. 
Ingredients: 
Table: 2.Mineral and Metal ingredients 
S.NO NAME OF DRUGS CHEMICAL NAME QUANTITY 
1. Manosilai Realgar 35mg (1 palam) 
2. Aridhaaram Orpiment 35mg (1 palam) 
3. Kaantham MagneticOxide of Iron 35mg (1 palam) 
4. Pooram Calomel 35mg (1 palam) 
5. Lingam Cinnabar 35mg (1 palam) 
6. Rasam Mercury 35mg (1 palam) 
7. Kanthagam Sulphur 35mg (1 palam) 
8. Vellaipadanum White Arsenic 35mg (1 palam) 
 
Table: 3.Herbal ingredients 
 
 
 
 
 
 
 
S.NO Drug name Botanical name quantity 
1. Kuppaimeni Acalyphaindica 60 ml 
2 Vetrilai Piper betle 60 ml 
3 Paruthi Gossipiumherbaceum 60 ml 
4 Vellarugu Enicostemmaaxillare 60ml 
5 Tulasi Ocimum sanctum 60ml 
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Collection of the Drug:  
 The mineral and metal ingredients of the drug were purchased in Govinda raja 
Mudhaliyar store, Parry‟s corner, Chennai-600001 and herbal ingredients were collected in 
and around Salem area.  
Identification and Authentication of the drug: 
 The minerals and metals were identified and authenticated by Gunapadam experts, 
P.G Dept. of Gunapadam, GSMC, Arumbakkam, Chennai-106. 
Purification process: 
      Purification process done as per Siddha classical literatures 
1. Realgar: 
Realgar(50gm)was soaked in ginger juice (Gingiberofficinalis- 50 ml) in the mud plate and 
then dried to get purified Realgar
[68A]
. 
2. Orpiment: 
        Orpiment (50gm) piece was buried in a heap of lime stone. Palm toddy was poured on 
the lime stone for 10 times and then washed and dried to get purified Orpiment
[68B]
. 
3. Magnetic Oxide of Iron: 
       Magnetic Oxide of Iron (50gm) was soaked in 300 ml  ofPonnavara root juice (Cassia 
auriculata -300ml) from morning to evening for ten days. Then it was dried for another two 
days without adding the juice. This process was repeated two times and washed to get 
purified Magnetic Oxide of Iron
[68C]
. 
4. Calomel: 
          The poultice made of betel leaf (Piper betle) and pepper (Piper nigrum) each 8.75 gm 
are taken and dissolved in 1.3 litre of water. Calomel (50gm) is tied with a cloth and 
immersed in the liquid from the cross bar and heated. After the water is reduced to ¾ of its 
volume, the Calomel is taken out, washed with water and dried to get purified Calomel 
[68D]
. 
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5.Cinnabar: 
       Cinnabar (50 gm) was soaked in Cow‟s milk (50 ml) in a mud plate for one day. Next it 
was soaked in lemon juice (50 ml) in the same mud plate for one day. Then it was washed 
thoroughly with water and dried to get purified Cinnabar
[68E]
. 
6. Mercury: 
Mercury                          -     35gram 
       Brick powder                   -      15 gm 
       Turmeric powder              -  20 gm 
Acalyphaindica juice      -            1.3 litre  
Mercury was triturated with finely powdered brick and then turmeric powder for one hour 
respectively and washed with water. Then Mercury was boiled with the juice of 
Acalyphaindica till the juice completely evaporates. We get purified Mercury
[68F]
. 
7. Sulphur: 
Sulphur(50gm) was placed in an Iron spoon. A small quantity of cow‟s butter was added and 
the spoon was heated till the butter melts, the mixture was immersed in inclined position in 
cow‟s milk. This procedure is repeated for 30 times to get purified Sulphur. Each time fresh 
milk is to be used
[68G].
 
8. White Arsenic: 
          White Arsenic (50gm) was powdered and triturated with lemon juice. It is made into 
small cakes and dried. This process is repeated for 7 times to get purified White Arsenic 
[68H]
. 
Preparatory method of AshtaBairavaChendooram: 
1. Purified Realgar                                    -         35gm 
2. Purified Orpiment                   -         35gm 
3. Purified Magnetic Oxide of Iron          -         35gm 
4. Purified Calomel                 -    35gm 
5. Purified Cinnabar       -     35gm 
6. Purified Mercury     -    35gm 
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7. Purified Sulphur                -         35gm 
8. Purified White Arsenic                         -         35gm 
Juice of the following herbals, 
1. Acalyphaindica -           60 ml 
2.  Piper betle                                         -            60 ml 
3. Gossypiumherbaceum-                      -            60 ml 
4. Enicostemmaaxillare-                    -            60 ml 
5. Ocimum sanctum                                 - 60ml 
Procedure: 
                All the above mentioned metal and mineral ingredients were taken, powdered 
separately and ground well in akalvam (stone mortar). Kuppaimeni juice was added to it 
ground for 3 hours. Then it was ground by adding Vetrilai, Paruthi, Velarugu, Thulasi 
respectively for 3 hours each. The mixture was made in to pellets and allowed to dry. The 
pellets were kept in a mud pot covered by betel leaf paste.  This is covered by another pot and 
their mouths are sealed with seven layers of mud sealed cloth. Then it was ignited for 12 
hours using deepakkini (small flame). Finally the clay smeared cloth was removed and the 
pots were separated. The Chenduramwas found sticking to the upper pot. This was collected 
by a clean spoon and labeled as AshtaBairavaChenduram (ABC). 
Storage: 
             The drug was stored kept in an air tight glass container. 
 Total chendooram    - 65gm 
 Weight of wastage   - 190gm 
Dosage                      -Kundrimanialavu( 130mg). 
Adjuvant - honey 
Indications: 
Kannaputru, Sanni 13,  Kuttam, Kiranthi 9, Pilavai, Putru 
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SULPHUR  WHITE ARSENIC 
Figure: 1 Metal ingredient of the drug ABC 
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Ocimum sanctum 
` Figure:2 herbal ingredient of the drug ABC 
 
 
 
 
 
 
 
       Preparation of Cakes                      Arrangement in Mud Pot 
 
Burning process 
 
PREPARATORY METHOD OF DRUG 
MATERIALS AND METHODS 
 
ANTI -CANCER  ACTIVITY OF ASHTA BAIRAVA CHENDURAM   80 
 
 
  
 
 
 
 
AshtaBairavaChenduram 
Figure: 3 Preparatory method of drug 
Analysis as per classical Ayushguideliness: 
1. Floating on Water: 
 A pinch of Chenduram gently placed over water kept in a vessel, did not sink 
immediately. It was found that the Chenduramparticles floated over the surface of water 
indicated lightness of the trial drug. 
2. Lines on fingers: 
Chenduramin well prepared form should be fine. When taken between thumb and 
index finger, the fine powder will fill up the lines of the finger print. A pinch of 
AshtaBairavaChenduramwas taken in between the thumb and index finger and rubbed. It was 
found that the AshtaBairavaChenduramentered into the lines of the finger, and was not easily 
washed out from the lines, confirmed its fineness. 
3. Irreversible reaction: 
 The well prepared chenduram is not reversible to its metallic state when heated with a 
mixture of cane jaggery, hemp powder, ghee and honey. A pinch of 
AshtaBairavaChenduramwas taken and mixed with cane jaggery, ghee and honey. It was 
observed that the AshtaBairavaChenduramdid not become  reversible to its metallic state. 
4. Tastelessness:  
The well prepared Chenduramshould be completely tasteless. Presence of any taste  
like sweet or bitter indicate incomplete preparation which needed another calcination process. 
When a small amount ofAshtaBairavaChenduramwas kept on the tip of the tongue, no 
specific taste was found. 
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5. Lusterless: 
If any shining particle present in Chenduram, it indicates that the chenduramis not 
manufactured properly and contains incomplete form of substances like minerals, metals and 
other toxic substances. There should be no shining particles present in the 
wellmanufacturedChenduram. The AshtaBairavaChenduramwas taken in a Petri bowl and 
observed for any lustre in daylight through magnifying glass. No lustre was observed in the 
Chenduram
[69A]
. 
4.2. STANDARDIZATION OF THE DRUGABC:
 
Standardization of drugs helps to prove its identity and determination of its quality 
and potency. Standardization of the herbo mineral formulation is based on the qualitative and 
quantitative analysis through physico‐chemical investigations and instrumental analysis. The 
physico-chemical analysis of the prepared herbo mineral drug have been done at Central 
Research Institute,Arumbakkam,Chennai and elemental analysis have been done  at 
IIT,Chennai(FTIR,SEM,ICP-OES,XRD).  
4.2.1. Physico‐Chemical Investigations: 
Physico‐chemical investigations like pH value, loss on drying at 105°C, action on 
heat, Flame test and Ash test have been done at Central Research Institute, Arumbakkam, 
Chennai as per the guide lines of AYUSH. 
pH value:  
Potentiometrically pH value is determined by a glass electrode and a suitable pH 
meter. 
Loss on Drying: 
The powdered drug is dried in the oven at 100- 105°C to constant weight.  
Action on heat: 
A small amount of the sample is taken in a dry test tube and heated gently. If strong 
white fumes evolve indicate the presence of Carbonate. 
Flame test: 
A small amount of the sample is made into a paste with conc.HCl in a watch glass and 
introduced into non-luminous part of the Bunsen flame. Appearance of bluish green flame 
indicates the presence of Copper. 
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Ash Test:  
A filter paper is soaked into a mixture of sample and Cobalt nitrate solution and introduced 
into the Bunsen flame and ignited. Appearance of yellow colour flame indicates the presence 
of Sodium.  
4.2.2 BIO-CHEMICAL ANALYSIS 
Preliminary Basic and Acidic radical studies:  
Preparation of extract 
              10g of sample was taken in a 250 ml of clean beaker and 50 ml of distilled water was 
added to it. Then it was boiled well for about 10 mins. Then it was allowed to cool and 
filtered in a 100 ml volumetric flask and made up to 100 ml with distilled water. This 
preparation was used for the qualitative analysis of acidic/ basic radicals and biochemical 
constituents in it. 
Test for Basic radicals 
1. Test for Potassium 
 To a pinch of the ABC 2 ml of sodium nitrate and 2 ml of cobalt nitrate solution in 
30% glacial acetic acid was added and observed for the presence of yellow precipitate. 
 
2. Test for Calcium 
To 2 ml of ABC extract, 2 ml of 4% ammonium oxide solution was added and observed for 
the formation of white precipitate. 
3. Test for Magnesium: 
To 2ml of ABC extract, drops of sodium hydroxide solution was added and watched 
for the appearance of white precipitate. 
4. Test for Ammonium: 
To 2ml of ABC extract few ml of Nessler's reagent and excess of sodium hydroxide 
solution are added for the appearance of brown colour. 
5. Test for Sodium 
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Hydrochloric acid was added with a pinch of the ABC, made as paste and introduced 
into the blue flame of Bunsen burner and observed for the appearance of intense yellow 
colour.  
6. Test for Iron (Ferrous) 
The ABC extract was treated with Conc. HNO3 and ammonium thiocyanate and 
waited for the appearance of blood red colour.   
7. Test for Zinc 
To 2 ml of the ABC extract drops of sodium hydroxide solution was added and 
observed for white precipitate formation.  
8. Test for Aluminium 
To the 2m1 of the ABC extract sodium hydroxide was added in drops and changes are 
noted.  
9. Test for Lead 
To 2 ml of ABC extract 2ml of potassium iodide solution was added and noted for 
yellow coloured precipitate.  
10. Test for Copper 
a. A pinch of ABC was made into a paste with con. Hcl in a watch glass and 
introduced into the non-luminous part of the flame and noted for blue colour appearance. 
b. To 2 ml of ABC extract excess of ammonia solution was added and observed for 
the appearance of blue coloured precipitate.  
11. Test for Mercury 
 To 2m1 of the ABC extract sodium hydroxide solution was added and noted for 
yellow precipitate formation.  
12. Test for Arsenic   
 To 2 ml of the ABC extract 2ml of sodium hydroxide solution was added and brown 
or redprecipitate formation was noted.  
Test for acid radicals 
1. Test for Sulphate 
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 To   2 ml of the ABC extract 5% of barium chloride solution was added and observed 
for the appearance of white precipitate.  
2. Test for Chloride 
 The ABC extract was treated with silver nitrate solution and observed for the 
appearance of white precipitate. 
3. Test for Phosphate 
         The ABC extract was treated with ammonium molybdate and conc. HNO3 and observed 
for the appearance of yellow precipitate. 
4. Test for Carbonate 
        The ABC extract was treated with conc.Hcl and observed forth appearance of 
effervescence. 
5. Test for Fluoride & Oxalate: 
To 2ml of ABC extract 2ml of dil.acetic acid and 2ml calcium chloride solution was 
added and heated and watched for cloudy appearance. 
6. Test for Nitrate: 
 To 1 gm of the ABC, copper turnings was added and again conc.H2SO4 was added, 
heated and the test tube was tilted vertically down  and observed for any changes
[69B]
. 
4.2.3 AVAILABILITY OF BACTERIAL LOAD: 
Enumeration of bacteria by plate count – agar plating technique 
 The plate count technique is one of the most routinely used procedure because of the 
enumeration of viable cells by this method.  
Principle:  
 This method is based on the principle that when material containing bacteria is 
cultured, every viable bacterium develops into a visible colony on a nutrient agar medium. 
The numbers of colonies therefore are the same as the number of organisms contained in the 
sample. 
[70]
 
Dilution:  
MATERIALS AND METHODS 
 
ANTI -CANCER  ACTIVITY OF ASHTA BAIRAVA CHENDURAM   85 
 
 Small measured volumes are mixed with a large volume of sterile water or saline 
called the diluent or dilution blank. Dilutions are usually made in multiples of ten. A single 
dilution is calculated as follows: 
              Volume of the sample 
   Dilution =  
     Total volume of the sample and the diluent 
Requirements: 
 Sample or Bacterial suspension 
 9 ml dilution blanks (7) 
 Sterile petri dishes (12) 
 Sterile 1 ml pipettes(7) 
 Nutrient agar medium (200 ml) 
 Colony counter [71]  
Procedure: 
1. Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7. 
2. Prepare the initial dilution by adding 1 ml of the sample into a 9 ml dilution blank 
labelled 10
-1
 thus diluting the original sample 10 times. 
3. Mix the contents by rolling the tube back and forth between hands to obtain uniform 
distribution of organisms. 
4. From the first dilution transfer 1 ml of the suspension while in motion, to the dilution 
blank 10
-2
 with a sterile and fresh 1 ml pipette diluting the original specimen to 100 
times. 
5. From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank with a 
fresh sterile pipette, thus diluting the original sample to 1000 times. 
6. Repeat these procedures till the original sample have been diluted 10,000,000 times 
using every time a fresh sterile pipette. 
7. From the appropriate dilutions transfer 1ml of suspension while in motion, with the 
respective pipettes, to sterile petri dishes. Three petri dishes are to used for each 
dilution. 
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8. Add approximately 15 ml of the nutrient medium, melted and cooled to 450c, to each 
petri dish containing the diluted sample. Mix the contents of each dish by rotating 
gently to distribute the cells throughout the medium. 
9. Allow the plates to solidity. 
10.  Incubate these plates in an inverted position for 24-48 hours at 370c[72]. 
Observation:Observe all the plates for the appearance of bacterial colonies. Count the 
number of colonies in the plates. 
 Calculate the number of bacteria per ml of the original suspension as follows: 
             Number of colonies (average of 3 replates) 
 Organisms per millimetre =  
Amount of plated × dilution 
 
4.2.4. SOPHISTICATED INSTRUMENTAL ANALYSIS 
FT-IR (Fourier Transform Infra-Red) 
Model   : Spectrum one: FT-IR Spectrometer 
Scan Range   :  MIR 450-4000 cm-1 
Resolution   :  1.0 cm-1  
Sample required :  50 mg, solid or liquid. 
 
It is the preferred method of infrared spectroscopy. FT-IR is an important and more 
advanced technique. It is used to identify the functional group, to determine the quality and 
consistency of the sample material and can determine the amount of compounds present in 
the sample. It is an excellent tool for quantitative analysis
[73]
. 
Sample preparation: 
In FT-IR infrared is passed from a source through a sample. This infrared is absorbed 
by the sample according to the chemical properties and some are transmitted. The spectrum 
that appears denotes the molecular absorption and transmission. It forms the molecular 
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fingerprint of the sample. Like the finger print there is no two unique molecular structures 
.the spectrum indicates the amount of material present.  
 FT-IR is the most advanced and the major advantage is, its 
 Speed 
 Sensitivity 
 Mechanical simplicity 
 Internally calibrated  [74] 
SEM (SCANNING ELECTRON MICROSCOPE) 
 In scanning electron microscope high-energy electron beam is focused through a 
probe towards the sample material. Variety of signals was produced on interaction with the 
surface of the sample. This results in the emission of electrons or photons and it is collected 
by an appropriate detector
[75]
. 
The types of signal produced by a scanning electron microscope include  
 Secondary electrons 
 back scattered electrons 
 characteristic x-rays, light 
 specimen current 
 Transmitted electrons. 
This gives the information about the sample and it includes external morphology, texture, 
its crystalline structure, chemical composition and it displays the shape of the sample 
[76]
. 
ICPOES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY) 
 Manufacturer: Perkin Elmer 
Model:  Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer (ICP) 
Principle: 
An aqueous sample is converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which is a high temperature zone (8,000– 
10,000ºC). The analysts are heated (excited) to different (atomic or ionic) states and produce 
characteristic optical emissions (lights). These releases are separated based on their respective 
wavelengths and their strengths are measured (spectrometry). The intensities are proportional 
to the concentrations of analysis in the aqueous sample. The quantification is an external 
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multipoint linear standardization by comparing the emission intensity of an unknown sample 
with that of a standard sample. Multi-element calibration standard solutions are prepared 
from single- and multi element primary standard solutions. With respect to other kinds of 
analysis where chemical speciation is relevant (such as the concentration of Ferrous Iron or 
Ferric Iron), only total essential concentration is analysed by ICP-OES
[77]
. 
Application: 
The analysis of major and minor elements in solution samples. 
Objectives: 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 Develop and put on a method for the ICP-OES sample analysis 
 Enhance the instrumental conditions for the analysis of different elements 
 Probes the outer electronic structure of atoms 
 
Mechanism:  
In plasma emission spectroscopy (OES), a sample solution is presented into the core 
of inductively coupled argon plasma (ICP), which generates temperature of approximately 
8000°C. At this temperature all elements become thermally excited and emit light at their 
characteristic wavelengths. This light is collected by the spectrometer and passes through a 
diffraction grating that serves to resolve the light into a spectrum of its essential wavelengths. 
Within the spectrometer, this deflected light is then collected by wavelength and amplified to 
yield an strength of  measurement that can be converted to an elemental concentration by 
comparison with standardization values. 
The Inductively coupled plasma optical emission spectrometric (ICP-OES) analysis 
was done in SAIF, IIT MADRAS,Chennai-36 using Perkin Elmer Optima 5300 DV
[78]
. 
Sample preparation: 
Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" 
sampling methods whereby samples are introduced in liquid form for analysis. 
100 mg ABC was occupied in a clean, dry test tube. To this, 3 ml Nitric acid was 
added and mixed well and allowed for few minutes until the reactions were completed. And 
then, 25 ml of Refined water, was added to prepare digested solution. The digested sample 
solution was shifted into plastic containers and labeled properly. It was completed in Bio-
chemistry lab, Govt. Siddha Medical College, Chennai-106. 
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XRD (X-RAY POWER DIFFRACTION) 
           The XRD uses x-ray radiation. 
 Procedure: 
Sample Preparation: 
XRD can be done on a number of different kind of samples.The sample is a crystalline 
powder that had pressed into the sample holder, and it has hold at an angle of 45 degrees. 
Solid small volumes of sample taped on the microscope slide glass or thin films deposited on 
a substrate but will have varying degree of effectiveness. The result of the sample is based on 
the  sample‟s crystalline nature . 
Check the alarm light on the right hand side of the instrument and fill the XRD log 
spreadsheet on desktop. 
[79]
 
 
 FTIR ( Fourier Transform Infrared Spectroscopy) 
 
  
   Figure: 4 - FTIR INSTRUMENT     
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 Figure:5 - FTIR MECHANISM   
 
 
 
                         Figure: 6 - SEM- SCANNING ELECTRON MICROSCOPE 
 
 
 
MATERIALS AND METHODS 
 
ANTI -CANCER  ACTIVITY OF ASHTA BAIRAVA CHENDURAM   91 
 
SEM INSTRUMENT 
 
                  Figure: 7-SEM MECHANISM 
 
 
 
 
 Figure: 8-ICP-OES ANALYSER (Perkin Elmer Optima 5300 DV) 
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Figure: 9-X-Ray Diffraction analysis(XRD) 
4.3. TOXICOLOGICAL STUDIES 
INTRODUCTION:  
The acute toxic class method is a stepwise procedure with the use of 3 animals of a 
single sex per step. Depending on the mortality and / or the moribund status of the animals, 
on average 2-4 steps may be necessary to allow judgment on the acute toxicity of the test 
substance. Morbid animals or animals obviously in pain or showing signs of severe and 
enduring distress shall be humanely killed, and are considered in the interpretation of the test  
results  in  the  same  way  as  animals  that  died  on  test.  The method allows for the 
determination of an LD50 value only when at least two doses result in mortality higher than 
0% and lower than 100%. 
PRINCIPLE:  
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum  number  of  animals  per  step,  sufficient  information  is  obtained  on  the  acute 
toxicity  of  the  test  substance  to  enable  its  classification.  The substance is administered 
orally to a group of experimental animals at one of the defined doses.  The substance is tested 
using a stepwise procedure, each step using three animals of a single sex. Absence or 
presence of compound-related mortality of the animals dosed at one step will determine the 
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next step, i.e.; − no further testing is needed − dosing of three additional animals with the 
same dose − dosing of three additional animals at the next higher or the next lower dose 
level. The method will enable a judgment with respect to classifying the test substance to one 
of a series of toxicity classes.   
4.3.1.ACUTE ORAL TOXICITY – OECD GUIDELINES - 423  
Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co - operation and Development, Guideline-423. 
CPCSEA [Approval no:IAEC/XLIV/29/CLBMCP/2014] 
Animal: Healthy Wistar albino female rat weighing 200–220 gm 
Studies carried out on three female rats under fasting condition, signs of toxicity were 
observed for every one hour for first 24 hours and every day for about 14 days from the 
beginning of the study 
[80]. 
METHODOLOGY   
Selection of animal species:  
The preferred rodent species is rat, although other rodent species may be used.  
Healthy  young  adult  animals  of  commonly  used  laboratory  strain Swiss albino rat was 
obtained from Animal house of King‟s institute, Guindy, Chennai. Females should be 
nulliparous and non-pregnant.  Each animal at the commencement of its dosing should be 
between 8 and 12 weeks old and its weight should fall in an interval within±20 % of the mean 
weight of the animals.  The studies were conducted in the animal house of C.L.BaidMetha 
college of pharmacy, Duraipakkam, Chennai. 
Housing and feeding conditions:   
 The  temperature  in  the  experimental  animal  room  should  be  22ºC  (+3ºC). 
Although  the  relative  humidity  should  be  at  least  30%  and  preferably  not  exceed  70% 
other than during room cleaning the aim should be 50-60%. Lighting should be artificial, the 
sequence being 12 hrs light, 12 hrs dark. For feeding, conventional laboratory diets may be 
used with an unlimited supply of drinking water. Animals may be grouped and tagged by 
dose, but the number of animals per cage must not interfere with clear observations of each 
animal
[81] 
. 
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Preparation of animals:   
 The animals are randomly selected, marked to permit individual identification, and 
kept in their cages for at least 7 days prior to dosing to allow for acclimatization to the 
laboratory conditions
[82]
. 
EXPERIMENT PROCEDURE: 
Administration of dose 
AshtaBairavaChendooramprepared as per the classical Siddha literature was 
suspended in 2% CMC with uniform mixing and was administered to the groups of Wistar 
albino rats. It is given in a single oral dose by gavage using a feeding needle. Animals were 
fasted prior to dosing. Following the period of fasting, the animals were weighed and then the 
test substance was administered. After the substance has been administered, food was 
withheld for  further 3-4 hours. The principle of laboratory animal care was followed. 
Observations were made and recorded systematically and continuously observed as per the 
guideline after substance administration.  
The visual observations included skin changes, mobility, aggressively, sensitivity to 
sound and pain, as well as respiratory movements. They were deprived of food, but not water 
16–18 h prior to the administration of the test suspension. Finally, the number of survivors 
was noted after 24 h and these animals were then maintained for a further 14 days and 
observations made daily. The toxicological effect was assessed on the basis of mortality.  
Number of animals and dose levels 
Since this test drug has been under practice for long time and likely to be non-toxic, a 
limit test at one dose level of 2000 mg/kg body weight will be carried out with 6 animals   (3 
animals per step). 
Duration of Study                            :   48 hrs 
Evaluation                                        :   14 Days 
Limit test 
 The limit test is primarily used in situations where the experimenter has information 
indicating that the test material is likely to be nontoxic, i.e., having toxicity only above 
MATERIALS AND METHODS 
 
ANTI -CANCER  ACTIVITY OF ASHTA BAIRAVA CHENDURAM   95 
 
regulatory limit doses. A limit test at one dose level of 2000 mg/kg body weight was carried 
out with three animals per step. The test substance-related mortality was not produced in 
animals, so further testing at the next lower level need not be carried out.  
Observations 
 The animals were observed individually after dosing at least once during the first 
30mins and periodically during the first 24 hrs. 
 Special attention: First 1-4 hrs after administration of drug.  
 It is observed daily thereafter for a total of 14 days, except when they needed to be 
removed from the study and killed humanely for animal welfare reasons or are found 
dead. 
a. Mortality 
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 48.0 hour 
following drug administration on day 1 of the experiment and daily twice thereafter for 14 
days.   
b. Body weight 
Body weights will be recorded at day: ‐1, day 1, 2, 7 and 14 of the study 
c. Cage-side observation 
These include changes in skin and fur, eyes and mucous membranes and also 
respiratory, circulatory, autonomic and central nervous systems, somatomotor activity and 
behaviour patterns. Attention should be directed to observations of tremors, convulsions, 
salivation, diarrhoea, lethargy, sleep and coma. 
d. Gross necropsy 
All animals (including those which die during the test period are removed from the 
study) will be subjected to gross necropsy. Gross necropsy includes examination of the 
external surface of the body, all orifices, cranial, thoracic and abdominal cavities and their 
contents, brain, eye, thymus, lungs, heart, spleen, liver, kidneys, adrenals, testes and uterus of 
all animals 
Histopathology 
Microscopic examination will be carried out  in organs to show the evidence of any 
toxicity in gross pathology. 
Data and reporting 
All the data were summarised in tabular form showing the animals used, number of 
animals displaying signs of toxicity, the number animals found dead during the test or killed 
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for humane reasons, a description and the time course of toxic effects and reversibility, and 
necroscopic findings. 
Test substance and Vehicle  
  In order to ensure the uniformity in drug distribution in the medium the suspension 
was made by mixing AshtaBairavaChendooramwith 2% CMC solution and it was found 
suitable for dose accuracy.  
 
Justification for choice of vehicle 
The vehicle selected as per the standard guideline is pharmacologically inert and easy 
to employ for new drug development and evaluation technique. 
(Schlede E., Mischke U., Diener W. and Kayser D 1992;66: 455-470 ) 
 
4.3.2.REPEATED DOSE 28 DAYS ORAL TOXICITY STUDY OF 
AshtaBairavaChenduram in RATS – (OECD-407 guidelines) 
Justification for Dose Selection 
 The results of acute toxicity studies in Wistar albino rats indicated 
thatAshtaBairavaChendooram was non-toxic and no behavioural changes was observed up to 
the dose level of 2000 mg/kg body weight. On the basis of body surface area ratio between 
rat and human, the doses selected for the study were100mg/kg, 200 mg/kg and 400 mg/kg 
body weight. The oral route was selected for use because oral route is considered to be a 
proposed therapeutic route. 
Preparation and administration of dose 
AshtaBairavaChendooramat three doses respectively was suspended in 2 ml of 2% 
CMC in distilled water. It was administered to animals at the dose levels of 100, 200 and 400 
mg/kg. The test substance suspensions were freshly prepared every day for 28 days. The 
control animals were administered vehicle only. Administration was by oral (gavage), once 
daily for 28 consecutive days. 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals 
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 Ten rats (Five Male and Five Female) were in each group randomly divided into four 
groups for dosing up to 28 days. Animals were allowed acclimatization period of 7 days to 
laboratory conditions prior to the initiation of treatment. Each animal was fur marked with 
picric acid. The females were nulliparous and non-pregnant. 
OBSERVATIONS 
Experimental animals were kept under observation throughout the course of study for 
the following:  
Body Weight: Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study and at termination to calculate relative organ weights. From the data, group 
mean body weights and percent body weight gain were calculated.  
Clinical signs: All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
Mortality: All animals were observed twice daily for mortality during entire course of study. 
Functional Observations: At the end of the 4
th
 week exposure, „sensory reactivity‟ to graded 
stimuli of different types (auditory, visual and proprioceptive stimuli), „motor reactivity‟ and 
„grip strength‟ were assessed. 
Laboratory Investigations: Following laboratory investigations were carried out on day 29 
in animals fasted over-night. Blood samples were collected from orbital sinus using Sodium 
heparin (200IU/ml) for Blood chemistry and Potassium EDTA (1.5 mg/ml) for Haematology 
as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. On 28th day 
of the experiment, 24 h urine samples were collected by placing the animals in the metabolic 
cage with free access to tap water but no feed was given.  
 The urine was free from fecal contamination. Toluene is used as a preservative while 
collecting the sample. The sediments present in the urine were removed by centrifugation and 
the collected urine was used for biochemical estimations. On 29th day, the animals were 
fasted for approximately 18 h, then slightly anesthetized with ether and blood samples were 
collected from the retro-orbital plexus into two tubes: one with EDTA for immediate analysis 
of haematological parameters, the other without any anticoagulant and was centrifuged at 
4000 rpm at 4 °C for 10 minutes to obtain the serum. Serum was stored at 20 °C until 
analyzed for biochemical parameters. 
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Haematological Investigations: Blood samples of control and experimental rats was 
analyzed for hemoglobin content, total red blood corpuscles (RBC), white blood corpuscles 
(WBC) count and packed cell volume (PCV).  
Biochemical Investigations: Serum was used for the estimation of biochemical parameters. 
Samples of control and experimental rats were analyzed for protein, bilirubin, urea, BUN, 
creatinine, triglyceride, cholesterol and glucose levels was carried using standard methods. 
Activities of Glutamate oxaloacetate transaminase/ Aspartate aminotransferase (GOT/AST), 
Glutamate pyruvate transaminase/ Alanine amino transferase (GPT/ALT) and Alkaline 
phosphatase were estimated as per the colorimetric procedure.  
Urine analysis: Urine samples were collected on end of treatment for estimation of normal 
parameters. The estimations were performed using appropriate methodology.  
Necropsy:All the animals were sacrificed on day 29. Necropsy of all animals was carried out 
and the weights of the organs including liver, kidneys, spleen, brain, heart, and lungs were 
recorded. The relative organ weight of each animal was then calculated as follows; 
 Absolute organ weight (g) 
Relative organ weight = ____________________________________________ ×100 
     Body weight of animal on sacrifice day (g) 
Histopathology: Histopathological investigation of the vital organs was done. The organ 
pieces (3-5µm thick) of the highest dose level of 400 mg/kg were preserved and were fixed in 
10% formalin for 24 h and washed in running water for 24 h. Samples were dehydrated in an 
auto technicon and then cleared in Benzene to remove absolute alcohol.  Embedding was 
done by passing the cleared samples through three cups containing molten paraffin at 50°C 
and then in a cubical block of paraffin made by the “L” moulds. It was followed by 
microtome and the slides were stained with Haematoxylin-Eosin.  The organs included heart, 
kidneys, liver, ovary, pancreas, brain, spleen and  stomach, of the animals were preserved 
they were subjected to histopathological examination. 
Statistical analysis: Findings such as clinical signs of intoxication, body weight changes, 
food consumption, hematology and blood chemistry were subjected to One-way ANOVA 
followed by Dunnet‟smulticomparision test using a computer software programme GRAPH 
PAD INSTAT-3 version. 
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4.4PHARMACOLOGICAL STUDY:  
4.4.1 INVITRO ANTI- ORALCANCER ACTIVITY DETERMINATION BY MTT 
ASSAY 
Materials and methods: 
KB( skin  cancer cells) was initially procured from National Centre for Cell Sciences 
(NCCS), Pune, India and maintained Dulbeccos modified Eagles medium ( Gibco, 
Invitrogen). 
The KB cell lines was cultured in 25 cm
2
 tissue culture flask with DMEM 
supplemented with 10% FBS, L-glutamine, Sodium bicarbonate and antibiotic solution 
containing: Penicillin (100U/ml), Streptomycin (100µg/ml), and Amphoteracin B (2.5µg/ml). 
Cultured cell lines were kept at 37ºC in a humidified 5% CO2 incubator (NBS Eppendorf, 
Germany).  
The viability of cells were evaluated by direct observation of cells by Inverted phase 
contrast microscope and followed by MTT assay method.  
 Cells seeding in 96 well plate: 
Two days old confluent monolayer of cells were trypsinized and the cells were suspended in 
210% growth medium, 100µl cell suspension (5x10
4
 cells/well) wasseeded in 96 well tissue 
culture plate and incubated at 37ºC in a humidified 5% CO2 incubator.  
 Preparation of plant extracts and compound stock: 
 1 mg of compound sample was added to 1ml of DMEM and dissolved completely by 
cyclomixer. After that the extract solution was filtered through 0.22 µm Millipore syringe 
filter to ensure the sterility.  
Cytotoxicity Evaluation:After 24 hours the growth medium was removed, freshly prepared 
each plant extracts in 5% DMEM(Dulbecco‟s modified eagle medium) were five times 
serially diluted by two fold dilution (100µg, 50µg, 25µg, 12.5µg, 6.25µg in 100µl of 5% 
MEM) and each concentration of 100µl were added in triplicates to the respective wells and 
incubated at 37ºC in a humidified 5% CO2 incubator. 
Cytotoxicity Assay by Direct Microscopic observation: 
Entire plate was observed at an interval of each 24 hours; up to 72 hours in an 
inverted phase contrast tissue culture microscope (Olympus CKX41 with Optika Pro5 CCD 
camera)   and microscopic observation were recorded as images.  Any detectable changes in 
the morphology of the cells, such as rounding or shrinking of cells, granulation and 
vacuolization in the cytoplasm of the cells were considered as indicators of cytotoxicity.   
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Cytotoxicity Assay by MTT Method: 
Fifteen mg of MTT (Sigma, M-5655) was reconstituted in 3 ml PBS until completely 
dissolved and sterilized by filter sterilization.. 
After 24  hours of incubation period, the sample content in wells were removed and 
30µl of reconstituted MTT solution was added to all test and cell control wells, the plate was 
gently shaken well, then incubated at 37ºC in a humidified 5% CO2 incubator for 4 hours. 
After the incubation period, the supernatant was removed and 200µl of MTT Solubilization 
Solution (DMSO was added and the wells were mixed gently by pipetting up and down  in 
order to solubilize theformazan crystals). The absorbance values were measured by using 
microplate reader at a wavelength of 540 nm
[83]
. 
 
The percentage of growth inhibition was calculated using the formula: 
 
       Mean OD Samples  x   100 
                   Mean OD of control group 
4.4.2. In vitro Anti- tumour activity 
Cell culture materials 
OSCC cell lines were purchased from American Tissue Collection Centre (ATCC) and were 
maintained in Dulbecco‟s Modified Eagle‟s Medium (DMEM) and Ham‟s F12 (DMEM/F12) 
(Sigma-Aldrich, USA).HOS cell lines were purchased from ATCC and were maintained in 
DMEM high glucose. Culture media was supplemented with 10% Foetal Bovine Serum 
(FBS) and 1% penicillin/streptomycin. 
Cell apoptosis assay by flow cytometry 
Cellular apoptosis was determined using the AnnexinV-FITC Apoptosis Detection Kit I 
(Clontech Laboratories Inc, USA) according to the manufacturer‟sprotocol. OSCC and HOS 
cell lines were cultured at 6 × 10cells/ml and seeded in 60 mm dish. The cells were treated 
with free medium containing various concentrations of ABC for 6, 12 and 24 hour. Cells 
were harvested by trypsinization, then washed twice with cold PBS and centrifuged at 1000 
rpm. About 1 × 10
5 
-1×10
6
cells were then re suspended in 400 µl1×binding buffer, 
centrifuged again at 1000 rpm for 5 minutes and then supernatant was removed. Cells were 
re-suspended in 200 µl 1× binding buffer and transferred to a sterile flow cytometry glass 
tube. Five µl Annexin V-FITC and 10 µl propidium iodide were added and then incubated in 
the dark at room temperature. Cells were analyzed by flow cytometer at 488 nm. The 
distribution of cells was analyzed using Cell Quest software (Becton-Dickinson) in the flow 
% of viability  = 
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cytometer within 1 hour of staining. Data from 10,000 cells was collected for each data file. 
Apoptotic cells were identified as Annexin V-FITC-positive and P-negative cells. 
4.4.3.ANTIOXIDANT ACTIVITY:  
Method: 
          After the end of sub-acute toxicity study, the intermediate dosage group of animals 
were sacrificed and organs such as liver and kidneys were excised out and analyzed for 
oxidative stress markers. The concentration of oxidative stress markers such as Lipid 
peroxide, Glutathione, Glutathione peroxidase and Catalase were analyzed. Lipid peroxides 
(Thiobarbituric Acid Reactive Substances – TBARS) in tissues were assayed by the method 
of Yagi. 
[84]
 The colour formation with Thiobarbituric acid (TBA) was used as index. 
Reduced glutathione (GSH) was estimated by the method of Ellman in which yellow colour 
developed when Dithionitro-bis-benzoic acid (DTNB) added to the compounds sulfhydryl 
groups. 
[85]
Glutothione peroxidase (GPx) estimated by the method of Rotruck et al, 1973 in 
which H2O2 reduced to water whereas organic hydroperoxides reduced to alcohol at the 
expense of GSH. 
[86][87]
 The activity of Catalase (CAT) was determined by the method of 
Sinha. 
[88] 
In this assay, Dichromate in Acetic acid heated in the presence of Hydrogeperoxide 
converted to Perchromic acid and then to Chromic acetate. The formed chromic acetate was 
measured at 620 nm. 
FREE RADICAL SCAVENGING ACTIVITY:  
DPPH ASSAY (2, 2-diphenyl -1-picrylhydrazyl) 
             The radical scavenging activity of extracts was determined by using DPPH assay 
according to Chang et al[2001].The decrease in the absorption of the DPPH solution after the 
addition of an antioxidant was measured at 517 nm. Ascorbic acid (10mg/ml DMSO) was 
used as reference
[89]
. 
PRINCIPLE 
            1,1-Diphenyl-2-picryl hydrazyl is a stable free radical with red colour which turns 
yellow when scavenged. The DPPH assay uses this character to show free radical scavenging 
activity. The scavenging reaction between (DPPH) and an antioxidant (H-A) can be written 
as,  DPPH + [H-A] →DPPH-H + (A) 
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Antioxidants react with DPPH and reduce it to DPPH-H and as consequence the absorbance 
decreases. The degree of discoloration indicates the scavenging potential of the antioxidant 
compounds or extracts in terms of hydrogen donating ability. 
REAGENT PREPARATION 
0.1mM DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of ethanol.  
PROCEDURE 
    Different volumes (2.5µl - 40µl) of plant extracts were made up to a final volume of 40µl 
with DMSO and 2.96ml DPPH (0.1mM) solution was added. The reaction mixture incubated 
in dark condition at room temperature for 20 minutes. After 20 minutes, the absorbance of the 
mixture was read at 517nm. 3ml of DPPH was taken as control. 
CALCULATION 
                             Control-test          
% inhibition =                                × 100 
                              control 
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5. RESULTS AND DISCUSSION 
 
Many studies have been carried out to bring the efficacy and potency of the drug 
AshtaBairavaChenduram. The study includes literary collections, physicochemical 
and phytochemical analysis, instrumental analysis, toxicological study and 
pharmacological study. The drug AshtaBairavaChenduram has been selected for 
Anti-cancer activity in reference with the text “PranaRakshamardhaSindhu”Literary 
collections about the drug from various text books were done. Siddha literatures 
related to the drug bring the evidence and importance of its utility in treating the 
cancer.  
 Botanical aspect explains the identification, description, active principle and 
medicinal uses of the plants.  
 Gunapadam review brings the effectiveness of the drug in treating cancer.  
 Pharmaceutical review describes about the chenduram and its properties.  
 The pharmacological review explains about the methodology of Anti-cancer 
Activity and the drugs used.  
Modern and siddha aspect of the disease was also reviewed. 
Results of Siddha Standardization –Interpretation 
Colour: 
It is blackish brown in colour. The absence of shining indicates there is no free 
form of metals. 
Floating on water:  
 
AshtaBairavachenduramfloats on water. It is due to its less specific gravity. 
So, it possess the property ofchenduram. 
Finger print test:  
AshtaBairavachenduram impinged on the crevices of finger. This indicates the 
particles are fine and it is in micro size. 
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Lustreless& tasteless: 
It is lustreless and tasteless  
Table: 4.Siddha Standardization result of ABC 
 
 
 
 
 
 
 
 
S.No Parameter Result of ideal 
chenduram 
 
Result of  ABC Interpretation 
1 Colour Blackich 
 
 
Blackish brown Chenduram 
2 Floating on water Floats on water 
 
 
floats on water Lightness of drug 
3 Finger print test Impinged in 
the furrow  of 
fingers 
Impinged in the 
furrow of 
fingers 
 
4 Lustre 
 
 
Lustreless Lustreless Change of specific 
metallic character of raw 
material after ingnation. 
5 Taste 
 
No specific 
taste 
No specific taste Change of specific 
metallic character of raw 
material after ingnation. 
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Table: 5.Physical characterization of AshtaBairavaChenduram 
 
 
 
 
 
 
 
 
 
Table:6.PHYSICOCHEMICAL ANALYSIS 
S.NO Parameter Result 
1. Specific gravity 0.976 
2. Ph 5.57% 
3. Flame test + 
4. Ash test - 
5. Particle size Completely passes through sieve no.120 
6. Loss on drying at 105 
degree Celsius 
3.04% 
7. Total ash 26.87% 
 
8. Water soluble ash 4.27% 
9. Acid insoluble ash 0.82% 
 
 
 
 
Parameter Result 
Colour Brown in colour 
State of the drug Powder 
Consistency Fine powder 
Solubility Sparingly soluble in water, DMSO. 
Well soluble in acids (Hcl and H2So4) 
Sense on touch Fine 
Sense on taste Tasteless 
Sense of smell No significant smell is observed 
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Interpretation  
 The physicochemical analysis of the drug result reveals the Loss on drying, 
pH, Total Ash, water soluble ash and Acid insoluble ash.  
Discussion on physic- chemical parameters 
Solubility 
 Solubility is one of the important parameters to attain desired 
concentration of drug in systemic circulation the required pharmacological 
response. 
 The oral bioavailability depends on several factors including aqueous 
solubility, drug permeability etc. 
 The most frequent causes of low oral bioavailability are attributed to poor 
solubility and low permeability  
 ABC is soluble in major solvents, sparingly soluble in some of the 
solvents thereby it proves its efficiency of solubility in the stomach 
indirectly, increased in bio-availability. 
pH (potential hydrogen) 
 AshtaBairavaChenduram  shows slightly acidic pH. 
 This pH level plays a role in enzyme activity by maintaining the internal 
environment thus regulating the homeostasis. 
 It is also an important factor for drug absorption. Because of the acidic 
nature, the drug is more readily absorbed in an acid medium like stomach 
which enhance the bioavailability of the drug. 
Specific gravity 
 The trial drug AshtaBairavaChenduram shows specific gravity which is 
lesser than water. It shows its nature of absorption. 
Flame test 
 Water blue colour flame was found which indicates presence of amount of 
arsenic. 
loss on drying 
  The low moisture content of ABC indicates that it has long shelf life. 
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 Moisture increase can adversely affect the active ingredient; But 
AshtaBairavaChenduram moisture doesn’t damage it. 
 So the low moisture content of ABC offers maximum microbial stability. 
Ash Values 
 Total Ash value- low total ash value ABC richness of organic substances. 
 These organic compounds are responsible for the mineral supplements and 
therapeutic effect of AshtaBairavaChenduram. 
Acid insoluble ash 
 Lower the acid insoluble value better will be the drug quality. 
 The drug possesses a low value (0.82%) of acid insoluble ash indicating 
that the preparation did not contain any sand, dust and stones. 
Water soluble ash 
 Decreased water soluble ash value (4.27%) indicates easy facilitation of 
diffusion and osmosis mechanisms. 
 The wavenumbers from 4000 cm-1 to 1500 cm-1 gives details for 
identification of functional group. 
 The wavenumber from 1500 cm-1 to 400 cm-1 provides particulars about 
molecular fingerprint. 
 The above result showed the presence of functional group like alcohols, 
alkanes, amides inAshtaBairavaChenduram. 
 They may be responsible for the presence of anticancer action of ABC in 
Oral cancer. 
[90]
 
Table: 7.Results of basic radicals studies 
S.NO Parameter Observation Result 
1 Test for Potassium - Absent 
2 Test for Calcium 
 
Formation of white colour 
precipitate 
Present 
3 Test For Magnesium. - Absent 
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4 Test For Ammonium - Absent 
5 Test For Sodium 
 
 
 
Absent 
S.NO Parameter Observation Result 
6 Test for Iron (Ferrous)  Absent 
 
7 Test For Zinc 
 
-  Absent 
8 Test For Aluminium 
 
 
 
Absent 
9 Test For Lead 
 
- Absent 
10 Test for Copper 
 
- 
 
Absent 
11 Test For Mercury 
 
Formation of yellow 
precipitate 
Present 
12 Test for Arsenic 
 
Formation of brownish red 
precipitate 
Present 
 
Interpretation 
Calcium: 
More recent studies were conflicting, and one that was positive for effect 
(Lappe, et al.) did control for a possible anti-carcinogenic effect of vitamin D, which 
was found to be an independent positive influence from calcium-alone on cancer 
risk.A randomized controlled trial found that 1400–1500 mg supplemental calcium 
and 1100 IU vitamin D3 reduced aggregated cancers with a relative risk. 
[91]
 
 Ca
2+ 
play a dual role in this process considering its involvement in 
proliferation/activation and apoptosis of both cancer and immune cells. Ca
2+
 for a 
productive efficient immune response against cancer. 
[92]
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Mercury: 
Miles (1926) introduced perchloride of mercury as an antiseptic agent in rectal 
surgery. Goligher (1951), Morgan (1955) and Keynes (1961) introduced the technique 
of flushing the colon and rectum in restorative cancer surgery
[93]
. 
Royle (1964) described alleged mercury intoxication after using 200 ml of 1: 
500 perchloride of mercury solution as an anti-cancer agent in renal surgery.In all 
cases the uptake of mercury into the blood has been well below the toxic levels 
defined by Lane (1954)
[94]. 
Studies of the urinary output have confirmed the safety of this technique. It is 
therefore concluded that mercury perchloride is a safe anti-cancer agent when used as 
described in large bowel surgery
[95]
. 
Arsenic: 
During the 18
th
 and 19
th
 centuries, a number of arsenic compounds were used 
as medicines. In that Arsenic trioxide has been used in a variety of method of 
treatment over the past 500 years, but most commonly used in the treatment of cancer.  
In 2000, the FDA approved this compound for the treatment of acute 
promyelocyticleukemia that is resistant to ATRA. Recently new research has been 
completed in locating tumours using arsenic-74 (a positron emitter). The advantages 
of using the arsenic -74 isotope instead of the formerly used iodine-124 isotope  is 
that the signal in the PET scan is clearer as the body tends to carry iodine to the 
thyroid gland producing a lot of noise 
[96]
. 
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Table: 8.Result of acid radical studies 
S.NO Parameter Observation Result 
1. Test for Sulphate  Present 
2. Test for Chloride Formation of white 
precipitate 
Present 
3 Test for Phosphate  -  Absent 
4 Test for Carbonate - Absent 
5 Test for fluoride &oxalate - Absent 
6 Test For Nitrate - Absent 
 
Anti-Microbial load Result 
    Bacterial dilutions 
 
     Fungal dilutions 
 
Figure:10- Bacterial and Fungal Dilutions  
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These herbo-metal drug are prepare from plant material they are prone to 
contamination. The contamination of herbal drugs by micro-organism not only cause 
bio deterioration but also reduces the efficacy of drugs. 
The toxin produces by microbes makes herbal drugs unfit for human 
consumption because the contaminated drug may develop unwanted disease instead of 
disease being cured. 
 Here, the contaminations of chenduram have been examined by bacterial and 
fungal load. 
 Total bacterial load in 10-4 dilution is 8 and in 10-6 dilution is 2. 
 Total fungal load in 10-2 dilution is 5 and in 10-3 dilution is 2.  
 Here, the contamination of ABC is within the WHO norms. Hence, the drug is 
collected, prepared, stored and packed and decontaminated prior to formulation. 
Result of Anti-Microbial load: 
Table: 9 
 
 
 
 
 
 
 
 
 
Bacteria Fungi 
10
-4
 10
-6
 10
-2
 10
-3
 
8 2 5 2 
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FT-IR (Fourier Transform Infra-Red)  
 
 
Figure: 11. Graph image of FT-IR analysis 
Table: 10. Characteristic IR Absorption Frequencies of Organic Functional 
Groups of ABC 
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Characteristic IR Absorption Frequencies of Organic Functional Groups 
 
Functional Group Type of Vibration Characteristic Absorptions 
(cm-1) 
Intensity 
Alcohol  
O-H (stretch, H-bonded) 3407 strong, broad 
Alkane  
-C-H Bending 1365 Variable 
Alkene  
=C-H Bending 798 Medium 
=C-H Bending 844 Strong 
C=C Stretch 1624 Variable 
Alkyl Halide  
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DISSCUSSION: 
 The wavenumbers from 4000 cm-1 to 1500 cm-1 gives details for 
identification of functional group. 
 The wavenumber from 1500 cm-1 to 400 cm-1 provides particulars about 
molecular fingerprint. 
 The above result showed the presence of functional group like alcohols, 
alkanes, amides in AshtaBairavaChenduram. 
 They may be responsible for the presence of anticancer action of ABC in Oral 
Cancer 
OH 
 OH group of AshtaBairavaChenduram has higher potential towards inhibitory 
activity against microorganisms
[97]
. 
Phenols 
Functional Group Type of Vibration Characteristic Absorptions 
(cm-1) 
Intensity 
 
 
   
C-Br Stretch 594 Strong 
C-Br Stretch 542 Strong 
Aromatic  
C-H Stretch 1417 medium-weak, multiple 
bands 
C-H Stretch 1475 medium-weak, multiple 
bands 
Carbonyl  
C=O Stretch 1828 Strong 
Nitrile  
CN Stretch 2253 Medium 
Carboxyl  
OH-C-O Stretch 2344 strong, two bands 
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 Phenols of ABC possess highly Anti-Oxidant property which enhances its 
effect against the disease 
 The effect of phenols is currently of great awareness due to their anti-oxidative 
and possible anti-carcinogenic activities. 
 Free radicals react easily with phenols to abstract the hydrogen atom from the 
OH group. Phenolic acids and flavonoids also work as reducing agents, free 
radical scavengers and quenchers of single oxygen formation
[98]
. 
 Phenolic acids components take part important roles in the control of cancer 
and other human diseases. 
 Phenols are the most important groups of secondary metabolites and bioactive 
compounds. Hydroquinone is one of the phenolic group inhibits the free 
radical reactions. (cho7 Alchohol HTI) They are also an antioxidant substance 
capable of scavenging free superoxide radicals, anti-aging and reducing the 
risk of cancer. 
 Phenolic and flavonoids possess diverse biological activities, for example, 
antiulcer, anti-inflammatory, antioxidant, cytotoxic and antitumor, 
antispasmodic and antidepressant activities 
[99]
. 
Alkanes 
 Alkane derivative like bis (4-amino-5-mercapto-1,2,4-triazol-3-yl) possess 
anti- cancer activity
[100]
. 
Carboxylic acid 
 Benzene-poly-carboxylic Acid Complex (BP-CI) is a novel anticancer 
complex against human cancer cells. 
 Docosahexaenoic acid (DHA) is an omega-3 fatty acid. Its structure is a 
carboxylic acid (-oic acid) with a 22- carbon chain (Docosa-is Greek for 22) 
and six (hexa-) cis double bounds
[101]
. 
 DHA was revealed to increase the efficacy of chemotherapy in prostate cancer 
cells and a chemo protective effect in a mouse model was reported
[102]
. 
 It may also be used as a non- toxic adjuvant to increase the efficacy of 
chemotherapy. 
 In mice, DHA was found to reduce growth of human colon carcinoma cells 
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 The cytotoxic effect of DHA was caused by decrease in cell growth 
regulators
[103]
. 
Ether: 
 Certain ether lipids such as 1-0-octadecyl-2-0 methyl-rec-glycero-3-
phosphocholine represent a new class of antineoplastic agents. These ether 
lipids have been shown to be cytotoxic for a wide variety of tumors
[104]
. 
 
 
Figure: 12(a) Image of the drug by SEM analysis  
 
 
 Figure: 12(b)  Image of the drug by SEM analysis 
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Principle: 
Nanoparticles, according to the American Society for Testing and Materials 
(ASTM) standard definition, are particles with lengths that range from 1 to 100 nm in 
two or three dimensions.  
Advantages of nanoparticles: 
 Enhancing solubility of hydrophobic drugs, 
 Prolonging circulation time, 
 Minimizing nonspecific uptake, 
 Preventing undesirable side effects, 
 Improving intracellular penetration, 
 Specific cancer  targeting [105] 
The test drug ABC contains nanoparticles. 
 The presence of nanoparticles in the drug results in a better bioavailability and 
facilitates absorption. 
 Nanotechnology a promising way from cancer management towards cancer 
elimination. 
Results and Interpretation of SEM analysis:  
 The morphology of the ABC drug can be determined by SEM (FEI Quanta). A 
representative portion of each sample must be sprinkled onto a double side carbon 
tape and mounted on aluminium stubs, in order to get a higher quality secondary 
electron image for SEM examination. We have observed from SEM photographs that 
particles are spherical in shapes and sizes are in the range from 1 micron to 3 microns. 
Although the particle sizes of different batches showed similarity, it seems that these 
particles are aggregates of much smaller particles. When dispersed in an aqueous 
medium, these preparations form a negatively charged hydrophobic particle 
suspension. This hydrophobicity gives these particles a tendency to aggregate together 
to form larger particles. This ABC exhibited larger sizes and agglomeration of the 
particles. Therefore, the comparatively larger size may be due to the agglomeration of 
the particles by repeated cycles of calcinations involved in preparation 
[106]
. 
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Table:  11. ICP-OES RESULTS OF ASHTA BAIRAVA CHENDURAM 
 
 
 
 
 
 
 
 
 
 
 
DISSCUSSION 
Table: 12.AYUSH guidelines limit for heavy metals is as follows; 
 
 
 
 
 
The Inductively Coupled Plasma Optic Emission Spectrometry (ICP-OES) results 
showed that the heavy metals lead, Arsenic and cadmium were found below detection 
level. Mercury (0.321 ppm) was found within the permissible level in 
AshtaBairavaChenduram. Hence it may be safe for human consumption. It also 
shows the presences of physiologically important mineral like Calcium, Iron, Sodium, 
Phosphate, Magnesium, Potassium, Sulphur and Phosphorous 
[107]
. 
S. no Elements Detected levels 
1. Phosphours 18.541 mg/L 
2. Calcium 14.150 mg/L 
3. Sulphur 82.514 mg/L 
4. Iron 1.330 mg/L 
5. Mercury 0.982 mg/L 
6. Potassium 20.821 mg/L 
7. Sodium 103.110 mg/L 
8. Nickel BDL 
9. Lead BDL 
10. Arsenic BDL 
11 Cadmium BDL 
HEAVY METAL 
LIMIT 
MAXIMUM 
PERMISSIBLE 
Arsenic (As) 3 ppm (3 mg/kg) 
Cadmium (Cd) 0.3 ppm (0.3 mg/kg) 
Lead (Pb) 10 ppm (10 mg/kg) 
Mercury (Hg) 1 ppm (1 mg/kg) 
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XRD –Result of AshtaBairavaChenduram 
 
             Figure: 13 Graph image of the drug by XRD analysis 
 
DISSCUSSION: 
XRD pattern of AshtaBairavaChenduram shows the good crystalinity after 
calcination process. The major diffraction peaks are identified after XRD analysis. 
AshtaBairavaChenduram concluded that HgS in nanocrystalline range (31–56 nm), in 
association with organic molecules probably plays an important role in making it 
biocompatible and nontoxic at therapeutic doses. Other elements present in 
AshtaBairavaChenduram act as additional supplement and possibly help in increasing 
the efficacy of the formulation. 
[108]
 
 
Toxicological study: 
Acute oral toxicity study: 
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Table: 13.Dose finding experiment and its behavioral Signs of Toxicity for ABC 
Group  
 
 
Day 
Body weight Normal  
Assessments of posture 
 
Normal 
Signs of convulsion limb 
paralysis 
 
Absence  
Body tone 
 
Normal 
Lacrimation  
 
Absence 
Salivation  
 
Absence                                          
Change in skin colour   
 
  Normal                                    
 
Piloerection 
 
 Normal                                         
Defecation 
 
 Normal                                         
Sensitivity response 
 
Normal 
Locomotion  
 
 
Normal 
Muscle gripness 
 
 
Normal 
 
Rearing 
 
 
Normal 
Urination  
 
Normal 
 
 
 
 
 
Table: 14. Observation done: 
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1.Alertness 2.Aggressiveness 3. Pile erection 4. Grooming   5.Gripping   6. Touch 
Response  7. Decreased Motor Activity   8.Tremors 9 Convulsions 10. Muscle Spasm 
11. Catatonia 12.Musclerelaxant 13.Hypnosis 14.Analgesia15.Lacrimation 
16. Exophthalmos 17. Diarrhoea 18. Writhing   19 Respiration   20.  Mortality 
Acute toxicity: 
In the acute toxicity study, the rats were treated with different concentration of 
ASHTA BIRAVA CHENDHURAM from the range of 5mg/kg to 200mg/kg which 
did not produce signs of toxicity, behavioral changes, and mortality in the test groups 
as compared to the controls when observed during 14 days of the acute toxicity 
experimental period. These results showed that a single oral dose of the extract 
showed no mortality of these rats even under higher dosage levels indicating the high 
margin of safety of this extract. In acute toxicity test the ASHTA BIRAVA 
CHENDHURAM was found to be non- toxic at the dose level of 200mg/ kg body 
weight. 
[109]
 
Sub-Acute toxicity test  
The dose selected for the sub-acute toxicity study was 20mg, 40mg/kg of ASHTA 
BIRAVA CHENDHURAM. All the animals were free of intoxicating signs 
throughout the dosing period of 28 days. No physical changes were observed 
throughout the dosing period. No mortality was observed during the whole 
experiment. No abnormal deviations were observed. No significant changes were 
observed in the values of different parameters studied when compared with controls 
and values obtained were within normal biological and laboratory limits. The weights 
of organs recorded did not show any significant differences in the treatment and the 
Dose
mg/
kg 
1 
 
 
 
2 
 
3 4 5 6 7 8 9                                                                                                                                                             10 11 12 13 14 15 16 17 18 19 20
 + - - 
 
- - + - - - - - - - - - - - - + - 
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control group indicating that ASHTABIRAVA CHENDHURAM was not toxic to 
kidney, liver and spleen There was no significant changes were observed in 
hemoglobin (Hb), red blood cell (RBC), white blood cell (WBC), packed cell volume 
(PCV), Erythrocyte sedimentation rate (ESR) in all the treated groups as compared to 
respective control groups. Histopathology studies were carried out on liver, kidney 
and spleen and recorded. 
[110]
 
SUB ACUTE REPORTS :ASHTA BIRAVA CHENDHURAM 
Sub-acute oral toxicity 28-days repeated dose study 
Table.15.Body weight change of rat exposed to ABC 
Dose  
(mg/kg/day) 
Days 
         1        7      14      21  28 
Control 120.59±0.9
2 
122.79±0.87 123.52±1.82 127.29±1.12 131.25±1.05 
     20 125.45±1.1
3 
125.48±1.85 123.97±2.78 128.19±1.17 129.47±2.48 
    40 126.00±1.8
3 
129.04±2.24 132.09±1.26 133.21±1.74 135.09±1.14 
Values are mean of 3 animals  S.E.M 
Table: 16 Effect of ABC on Organ weight  in rats 
ORGAN CONTROL 20 mg/kg 40 mg/kg 
Liver(g) 3.07±0.20 3.27±0.11 2.76±0.08 
heart(g) 0.32±0.04 0.48±0.01 0.532±0.52 
lung(g) 0.28±0.05 0.34±0.04 0.4±0.06 
spleen(g) 0.25±0.06 0.31±0.07 0.35±0.08 
Brain(g) 0.37±0.05 0.50±0.05 0.05±0.03 
kidney(g) 0.76±0.05 0.93±0.02 0.73±0.04 
\Values are mean of 3 animals  S.E.M. (Dunnett's test). *P<0.05;  
**P<0.01;***P˂0.001 vs control N=3 
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Table: 17. Effect of ABC on Haematological parameters in rats 
Parameter Control 15 mg/kg 30 mg/kg 
RBC 
(x 10
6
/mm
3
) 
8.29 ± 0.43 8.05±0.53 8.05±0.53 
PCV (%) 49.66 ± 0.77 48.49±1.00 50.36±0.72 
Hb (%) 15.13 ± 0.19 14.6±0.23 12.93±0.28 
WBC 
(x 10
3
/mm
3
) 
11.75 ± 0.85 12.06±1.04 14.27±0.34 
Neutrophils 
(%) 
23.29 ± 0.73 23.27±0.76 24.04±0.58 
Lymphocytes 
(%) 
85.5 ± 0.46 85.9±0.50 88.14±0.58 
Eosinophils 
(%) 
4.10 ± 0.23 4.1±0.32 3.26±0.32 
Platelets 
(x 10
3
/mm
3
) 
425.73± 
1.35 
463.8±16.9 513.9±13.9 
Values are mean of 3 animals  S.E.M. (Dunnett's test). *P<0.05; 
**P<0.01;***P˂0.001   N=3 
Table: 18.Effect of ABC on biochemical parameters in rats 
Parameters Control 15 mg/kg 30 mg/kg 
Glucose  (g/dl) 108.63 ± 0.81 111.08±0.9 108.3±0.47 
Albumin (g/dl) 5.34 ± 0.40 5.65±0.71 6.98±0.53 
BUN (mg/dl) 22.06± 1.55 22.72±1.25 24.2±1.11 
Creatinine 
(mg/dl) 
0.85 ± 0.07 0.85±0.04 0.96±0.02 
Total Cholesterol 
( mg/dl) 
93.21± 1.16 93.8±1.50 93.03±1.15 
Triglycerides(mg/
dl) 
52.58 ± 1.56 54.7±1.56 52.23±1.12 
Total Protein 
(mg/dl) 
8.58 ± 0.68 8.8±0.66 7.91±0.54 
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Values are mean of  3 animals  S.E.M. (Dunnett's test). *P<0.05;  
**P<0.01;***P˂0.001  N=3 
Table: 19.Effect of ABC on Urine parameters in rats 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
SGOT (U/L) 74.35 ± 1.23 74.6±1.70 70.13±0.57 
SGPT(U/L) 27.07 ± 0.84 27.5±0.77 22.77±1.73 
Alkaline 
phosphatase(U/L) 
104.63 ± 1.14 105.2±1.19 99.9±0.65 
Parameters 
Control 20 mg/kg 40 mg/kg 
Colour Yellow Dark 
yellow 
Brown 
Transparency Clear Clear Dark 
Specific 
gravity 
1.010 0.9 0.8 
Ph 7.2 7.6 7.8 
Protein Nil + ++ 
Glucose Nil - - 
Bilirubin -ve Trace ++ 
Ketones -ve - - 
Blood Absent Nil Nil 
RBCs Nil Nil Nil 
Epithelialcells Nil Nil + 
Casts Nil Occasional + 
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Figure.15. Histopathology image of ABC 
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Results of In-Vitro Anti-Oral Cancer Activity 
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Table: 20.Cytotoxicity Assay by MTT 
 
 
 
 
 
 
 
 
 
LD50 values –140.6ug/ml (  ED50plus software V 1.0) 
 
MTT colorimetric method, also known, is a method for detecting cell survival 
and growth methods. This assay is based on the metabolic reduction of 3- (4, 5- 
dimethylthiazol-2-yl) -2, 5-difeniltetrazol (MTT) by mitochondrial enzyme succinate 
dehydrogenase in a colored compound blue (formazan), allowing to determine the 
functionality of the mitochondrial treated cells. This method has been widely used to 
measure survival and cell proliferation. The amount of living cells is proportional to 
the amount of formazan produced. Cell lines derived from NCCS, Pune were free 
from any kind of bacterial and fungalcontamination. 
AshtaBairavaChenduram at different doses (6.25-100 µg in100 µl of 5% 
MEM) was administeredfor 24 hrs. It was found that the number of cells decreases as 
the dose increases and at approximately 50 µg/mldose of extract, 50% of the cells 
(KB cells) were less as compared to normal control asshown in figure(15). The 
percentage of cells viability was determined by calculating the O.D of treated against 
thecontrol.  Reading optical density (OD) is performed in a spectrophotometer at a 
wavelength of 540 nm. Comparison values are made on a basis of 50% inhibition of 
growth (IC50) in treated cells with specific agents.  
Sample  
Concentration 
(µg/ml) 
 Average OD 
at  540nm 
Percentage 
Viability 
Control 0.4764  
6.25 0.4018 84.3409 
12.5 0.3747 78.6524 
25 0.3379 70.9278 
50 0.3012 63.2242 
100 0.2971 62.3635 
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Results are tabulated in Table-20 and graphically represented in Chart-1  
Anti-Cancer activity of Ashta Bairava Chenduram
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             Chart: 1 Anti-Cancer activity of ABC 
Chart -1shows the drug dose and % of Inhibition of KB cells after the 
AshtaBairavaChenduram extract treatment. It can be observed by the result of MTT 
assay that the IC dose of AshtaBairavaChenduram is 50µg/ml. As the dose increases 
the KB cell viability decreases. It was found that the % growth inhibition increasing 
with increasing concentration of AshtaBairavaChenduram steadily up to 6.25 µg / ml 
on KB cell line (Table-20 and Chart -1) and that IC value on KB cell line was 50 and 
R value was 0.9808. 
 
Analysis of Membrane Morphological Characteristics by Haematoxylin /Eosin 
(H/E) Staining  
Morphological changes such as changes to the cell membrane, loss of 
membrane asymmetry and cell shrinkage, are the early stage of apoptosis was 
analyzed by H/E staining. The IC dose (50µg/ml) treated cancer cells show features of 
apoptosis whereas treated with same amount of dose, to normal treated cells appeared 
without any significant changes.   
Since the discovery of the cisplatin antitumor activity, great efforts have 
focused on the rational design of metal-based anticancer agents that can be potentially 
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used in cancer chemotherapy. Over the last four decades, a large number of metal 
complexes have been extensively investigated and evaluated in vitro and in vivo. 
[111]
 
The key focuses of these studies lie in finding novel metal complexes which 
could potentially overcome the hurdles of current clinical drugs including toxicity, 
resistance and other pharmacological deficiencies. 
Metals and metal compounds have been used in medicine for several 
thousands of years. The medicinal uses and applications of metals and metal 
complexes are of increasing clinical and commercial importance. Monographs and 
major reviews, as well as dedicated volumes, testify to the growing importance of the 
discipline. 
[112]
 
The field of inorganic chemistry in medicine may usefully be divided into two 
main categories: firstly, ligands as drugs which target metal ions in some form, 
whether free or protein-bound; and secondly, metal-based drugs and imaging agents 
where the central metal ion is usually the key feature of the mechanism of action. 
Arsenic trioxide, As2O3(Trisenox, Cell Therapeutics Inc, Seattle,USA) which 
was approved by the FDA in September 2000 for treatment of acute 
promomyelocyticleukemia (APL) in patients who have relapsed or are refractory to 
retinoid and anthracyclinechemotherapy. An estimated 1,500 new cases of APL are 
diagnosed yearly in the US, of which an estimated 400 patients will not respond to, or 
will relapse from, first-line therapy. 
[113]
 
The approval ofarsenic trioxide as a chemotherapeutic agent invokes the 
pioneering work of Ehrlich and thedevelopment of Salvarsan for use in syphilis—the 
foundation stone for the science of chemotherapy. 
[114]
The use of chelating agents in 
medicine may even be traced to a collaboration between Werner (thefather of 
coordination chemistry) and Ehrlich (the father of chemotherapy) to find less toxic 
arseniccompounds for the treatment of syphilis. 
[115]
 
Arsenic has been used therapeutically for more than 2,000 years and was used 
in the 1930s for treatment of chronic myelogenousleukemia until supplanted by newer 
chemotherapies. 
[116][117]
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The past, present, and future of medicinal arsenic has been described as a story 
of ‘‘use, dishonor, and redemption’’. Recent interest in arsenic trioxide initially arose 
through Chinese reports of its efficacy and use. Side effects are cardiotoxicity, skin 
rashes, and hyperglycemia. 
[118]
 
Arsenic trioxide apparently affects numerous intracellular signal transduction 
pathways and causes many alterations in cellular function. Thus, the mechanisms of 
cell death induced by arsenic trioxide are multiple; inductions of apoptosis, inhibition 
of proliferation, and even inhibition of angiogenesis have all been reported. 
[119][120]
 
In cellular studies, arsenic trioxide inhibits glutathione peroxidase, possibly 
through generation of arsenic–GSH conjugates, and increases cellular hydrogen 
peroxide content. 
[121]
 
Several pieces of evidence indicate that iron deprivation could be an excellent 
therapeutic approach: (i) dietary iron restriction markedly decreases tumour growth in 
rodents 
and antibodies which block transferrin-binding to ellular receptors inhibit cancer cell 
growth in vitro and invivo.
.[122][123] 
Sulphur is commonly used in Asia as an herbal medicine to treat inflammation 
and cancer. Organic sulphur has been studied on oral and other cancers and has been 
found to have remarkable benefit in anti-cancer therapy. 
[124]
 
Oncologists and scientists engaged in the research of cancer treatments should 
conduct a comprehensive study on the efficacy of mercury which is being used as an 
anti-cancer drug in the age old Siddha system.  
[125]
 
Three years of research has shown that metal (mercury, arsenic and copper) 
based Siddha drug is a safe alternative for cisplatin therapy or arsenic trioxide in 
selected cases of cancer treatments wherein the patients cannot bear the adverse 
effects. He found that mice treated with Siddha drugs showed better health than what 
did in cisplatin therapy in terms of appetite, haemoglobin, red blood cells and white 
blood cells. 
[126]
 
Studies have shown that phenols present in herbal plants such as 
Acalyphaindica, Piper betel, Gossypiumherbaceum, Enicostemmaaxillare, Oimum 
sanctum have cytotoxic effects on different tumors. Mechan+isms of these 
compounds are carried out through apoptosis. Thus from the above study, it is evident 
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that the cytotoxic property of AshtaBairavaChendurammay be due to the synergistic 
interactions between the metal complex and plant derivatives. 
 
 
 
 
Figure: 15 -Morphological Effect Of ABC On Kb Cell Line 
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RESULT AND DISCUSSION 
Anti- tumour activity 
Cell apoptosis assay results  
The dual parameter fluorescent dot plots (Fig -16) shows the viable cell population in 
quadrant 3 (negative annexin-FITC and negative PI), the cells at the early apoptosis 
are in quadrant 1 (positive annexin-FITC and negative PI) while the ones at the late 
apoptosis are in quadrant 2 (positive annexin-FITC and positive PI).As seen in fig :16 
control untreated cells were mostly alive whereas when the ABC treatment was 
applied, the early apoptotic cells percentage increased in relation to its concentration. 
The box plot percentages of cell populations revealed that effect was dose and time 
dependent. 
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Figure: 16 Apoptotic effects of ABC on (a) OSCC and (b) HOS cell lines were 
determined by flow cytometry analysis using annexin V-FITC and propidium iodide. 
The experiments were performed after treatment with 2% and 5% ABC for 6, 12 and 
24 hrs. Cell populations in bottom left, bottom right, top right and top left quadrants 
represented the proportion of viable cells, necrotic cells, late apoptotic cells and early 
apoptotic respectively. 
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DISCUSSION 
In this study, we investigated the antiproliferative and apoptotic activities of ABC on human 
OSCC and HOS cell lines. The present study showed that ABC has potential time and dose 
dependent anti - proliferative effect on OSCC and HOS cancer cell lines. We found that ICfor 
ABC was 4% for OSCC and 3.5% for HOS cell lines. As shown by our flow cytometry 
results, when the concentration of ABC was increased, the percentage of early apoptotic cells 
also increased. For this reason, the mode of cell death appears to be due to early apoptosis 
cell death pathway.  
Conclusion 
In conclusion, the results of this study suggest that ABC has a promising anti- proliferative 
and apoptotic effect on OSCC and HOS cell lines. Early apoptosis could be attributed, in part, 
to its ability to inhibit proliferation. Further investigations are needed to determine the 
molecular mechanisms involved in apoptosis. 
AntioxidantActivity 
Table- 21.DPPHAssayofAshtaBairavaChenduram 
 
Concentration (µg/µl)
* 
Absorbance Percentage of 
inhibition 
AshtaBairavaChenduram Drug Standard Drug Standard 
Control 0.9857 0.341 - - 
1.25 0.9693 0.299 20.78 40.89 
2.50 0.9516 0.232 31.59 51.25 
5.00 0.8839 0.114 43.45 74.07 
10 0.7567 0.092 55.24 83.33 
20 0.6392 0.054 62.12 89.62 
 
*µg/ml: microgram per millilitre. Drug:   AshtaBairavaChenduram(1.25-20µg/µl). Standard: 
Ascorbic acid(10mg/mlDMSO) 
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 Chart: 2 DDPH Assay of ABC 
 
 DPPHstablefree radicalmethodis 
aneasy,rapidandsensitivewaytosurveytheantioxidant activity 
ofAshtaBairavaChenduramextract.  The antioxidant molecules can  quench  DPPH free 
radicals by providing hydrogen  atomorbyelectron  donation  and a colorless stable 
molecule 1, 1 diphenyl-2-
picrylhydrazilisformedandasaresultofwhichtheabsorbanceat517nmofthe 
solutionisdecreased.In 
thepresentstudy,theAshtaBairavaChenduramextractwasanalyzedwasableto 
decolorizeDPPH and thefreeradicalscavengingactivity wasexpressedasthepercentage 
decreaseinabsorbance. 
The results show that the extracts of AshtaBairavaChenduram and the standard 
drug Ascorbic acid (10mg/mlDMSO) have a concentration-dependent anti-radical activity 
which was tabulated in Table No.21 
A maximum of 62.12% and 89.62% anti-radical effects are exercised by 
AshtaBairavaChenduram and standard drug ascorbic acid at concentrations of 20 µg / ml 
respectively. Minimum percentageofinhibition20.78% and 40.89% % anti-radical effects are 
manifested by AshtaBairavaChenduramand standard drug ascorbic acid at concentrationsat 
1.25µg/ml.Thisindicated that%ofinhibitionincreased withincreaseinconcentration ofboth 
thestandardandAshtaBairavaChenduramextract. But theAshtaBairavaChenduramextracthas 
lowerDPPHscavengingactivitythanthatof standard. From the present study, it was 
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concluded that the AshtaBairavaChenduramextracthasgood 
antioxidantactivityathigherconcentrations. 
It is known that oxidative stress induced cell damage not only through damage to 
proteins, lipids and DNA. It may also alter signaling pathways redox sensitive to changes 
involved in the response of apoptosis. The antioxidants are currently the subject of many 
studies because, in addition to some interest in the preservation of comestibles, they could be 
useful in the prophylaxis and treatment of diseases in which oxidative stress is implicated. 
Many studies realized on natural products have proven that they are especially phenolic 
compounds who are responsible for their antioxidant activity. 
Several studies have shown the link between the traditional drug formulations rich in 
antioxidants and the incidence certain diseases such as cancer, heart disease, diabetes and 
other diseases related to aging.Phenolic compounds could prevent cancer by the action 
antioxidant and / or the modulation of several functions of proteins. Phenolic compounds can 
prevent carcinogenesis by affecting the molecular events in the triggering, promotion and 
progression stages. 
Some phenolic compounds (phenolic acids, flavonoids, quinones, coumarins) have 
proved an effective antioxidant activity and also had anticancer activities/ anticarcinogenic/ 
antimutagenic. 
Here, the reactive oxygen species (ROS) may be the triggers apoptotic process. In 
recent years they have been described numerous properties of these compounds such as the 
ability to inhibit cell cycle, proliferation cellular and oxidative stress, and induce 
detoxification enzymes, apoptosis, and stimulate the immune system. It is therefore 
hypothesized that AshtaBairavaChenduram of its antioxidant power could ―to repair" Cancer 
cellsti –oxidant activity 
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6. CONCLUSION 
In the rat body weight examination it was found that as the days progressed the average 
weights of ascended up a little for controls and 15mg but weight descended gradually in mid 
and high dose group. However none of these were statistically significant, hence these 
variations can be ignored. 
During organ weight examination there was a significant increase in kidney weight 
with the increase in dosage reaching high organ weight at 60mg/kg (P<0.001). Hence it has 
been advised to try this medicine with low and mid dosage. 
In the examination of haematological and biochemical parameters there were notable 
changes in the experimental group when compared to control group. Though these variations 
are statistically significant all these changes are within normal limits.  
Anti-cancer activity of the ABC is clearly visible from the MTT and DPPH assay. MTT 
assay result shows a high variation in cell viability of human oral cancer cell line. In addition 
it has been found cell viability variation increases with the increase in duration with the 
15mg/ml dosage. This clearly shows the anticancer activity of the ABC. 
In the DPPH assay the effectiveness in scavenging the free radical are measured. From 
the DPPH assay result we can conclude there is mean percentage reduction of free radicals 
during the dose level (15mg/ml) of ABC. 
As a whole, haematological and biochemical variation are with in reference range. 
Body weight, organ weight and food consumption variations between control and 
experimental group were not significant. Anti-cancer activity of the ABC was well showed 
off from the MTT and DPPH assay. 
From this we can conclude ABC is well tolerated by albino rats. Moreover considering 
all the above results ABC is not only found to be safer and without adverse effect it is also 
found to be more effective as an anti-cancer drug in minimal dose. This drug should be taken 
for further evaluation on a larger cohort. That will bring out an effective drug which would 
cast a bright light in the darkness of cancer therapy. 
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                             7.SUMMARY 
 The evaluation of therapeutic efficacy of the trial drug is “AshtaBairavaChenduram” 
from the Siddha literature “Pranarakshamirthasinthu” against Oral Carcinoma (kannaputtru) 
is dealt with in the entire study. Introduction of the study comprises about the prevalence of 
Carcinoma worldwide, which is found to be the major cause of the death in human. It is the 
right time to explore the therapeutic values of classic preparation against life threating 
malignancies to the society. 
 In the Drug Review,details about the therapeutic efficacy, active principles of Arsenic 
compounds and other ingredients and their role in the Siddha formulations indicated for 
Cancer are discussed. 
SEM analysis revealed the size of the drug particle is in nanometer which implies that 
the drug could have potent drug delivery.  
FTIR analysis found the presence of Phenolic groups which could act as an anti-
oxidant and prevent classical risk factors free radicals of Cancer. 
The acute and Sub-acute toxicity study exposed that the drug belonged to Class II and 
hence, we can use it for a long period. 
So, based on all results it can be concluded that the anticancer activity of the drug in 
minimal dose in Oral Squamous Cell Carcinoma cell line proved it to be an effective 
anticancer drug and Lipid peroxidation - TBARS assay shown effective antioxidant activity.   
All physicochemical analysis, elemental analysis and pharmacological evolution 
revealed that AshtaBairavaChendooram is an excellent traditional medicine in the 
management for Oral cancer. 
 The final discussion and conclusion parts provide a brief description of the entire 
analysis of study. The conclusion chapter also provides a discussion of the verification and 
validity of the research results carried out. The most vital part of some experience of the 
findings in the dissertation is also discussed and thereafter invites anyone who is ambitious  
to further studies and future research possibilities.  
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8.FUTURE SCOPE 
The trial drug Ashta Bairava Chenduram is a potent herbo-mineral 
formulation with anti - cancerous properties which has been elaborated in the study. 
The above study performed in cell lines demonstrates the effectiveness of the drug 
Ashta Bairavan chenduram against oral carcinoma. Further evaluation of potency of 
the drug has to be explicitly done pre-clinically and clinically in future. 
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